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Mechanical stretch, a normal physiologic signal in the vascular system, regulates vascular 
development and regeneration, but the mechanisms underlying these endothelial (EC) 
and smooth muscle cell (SMC) responses remain unclear.  We hypothesized that cyclic 
tensile strain can regulate autocrine or paracrine signaling between vascular cells to 
activate concerted angiogenic responses.  In order to systematically examine vascular cell 
response to cyclic tensile strain, a high precision computer controlled strain device was 
designed and elastomeric substrates to present defined strain profiles, for 2D and 3D 
studies, were created.   
 
It has been demonstrated that cyclic strain can alter EC phenotype and Angiopoietin-2 
(Ang-2) expression, and the alterations in Ang-2 mediated changes in EC migration, and 
in vitro capillary formation.  Knockdown of endogenous Ang-2 expression via RNAi, 
however, decreased EC responsiveness to strain mediated EC angiogenic processes.  We 
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concluded that autocrine signaling via activation of Ang-2 may be one of the mechanistic 
pathways by which ECs transduce mechanical strain signals to process early angiogenic 
responses.  Cyclic strain also regulated EC secretion of platelet derived growth factor 
(PDGF), a known chemotactant for SMCs. Application of strain gradients on isolated 
vascular EC and SMC colonies in co-culture regulated EC secretion of chemotactic 
gradients, and this gradient directed SMC recruitment towards strain-mediated EC 
migration.  It is concluded that cyclic strain can modulate the intercellular 
communication between ECs and SMCs by mediating chemotactic paracrine factors.  
Taken together, our studies show that the application of precise local cyclic tensile strain 
signals enables one to regulate the behavior of cells at the molecular level by regulating 
autocrine signals (EC to EC) via Ang-2 and paracrine signals (EC to SMC) via PDGF to 
















1.1 Problem Statement 
Tremendous achievements in science over the past centuries have laid platform for 
medical discoveries that largely impact today’s society.  These advancements provide 
enumerable cures and treatments that improve our lives in many aspects.  Benefits from 
enhanced awareness due to scientific research and resultant treatments is clear in diseases 
associated with the cardiovascular where mortality rates have diminished by 4 million 
individuals over the past 50 years1.  However, over 25 million people still continue to 
suffer annually due to heart disease related issues, the leading cause of death in the 
United States (Figure 1.1). 
 
Tissue engineering has emerged over the past three decades to address the growing need 
for biological substitutes to restore or replace damaged tissues and organs2 (Figure 1.2).  
Current approaches to organ repair rely primarily on transplantation of whole or partial 
organs and tissues.  The imbalance of need versus availability of organs poses as a 
significant and inherent limitation to this method 3.  Tissue engineering promises an 




Figure 1.1:  Mortality rates for leading causes of death in the United States. 
Heart disease remains the leading cause of death over the past 50 years in the United 
States (1950-2003).  Aside from deaths due to unintentional injuries, understanding how 
to regulate blood vessel development would largely impact therapies for other leading 
causes of death shown above, such as cancer, stroke and chronic lower respiratory 
diseases. (Image adapted from CDC, 20031) 
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participation of matrices that guide tissue regeneration while providing specific 
instructions with signaling molecules.   
 
In order to develop functional tissue engineering constructs, an intact vasculature must be 
present.  Overcoming this challenge is a major limitation that hinders this technology 
from clinical application.  The goal of this thesis is to induce the formation of vascular 
networks within the tissue engineered constructs, by utilizing external stimuli to guide the 
network formation rather than utilizing artificial vascular constructs to ensure appropriate 
nutrient provision to all tissues.  Vascularization in tissues is limited by oxygen’s 
diffusion coefficient, where after a maximum penetration length of 200um, cells 
experience hypoxic conditions4.  Therefore in order to sustain sufficient gas and exhaust 
exchange, to maintain cell viability within tissue engineered constructs, it is vital to 
understand how to control and develop new vascular networks. 
 
Physiologically, the phenomenon of vascular remodeling occurs during embryogenesis as 
well as into adult life, particularly during times of physiologic change or pathological 
states.  Understanding the factors that regulate vascular development gives insight to 
therapeutic approaches to blood vessel associated heart diseases that remain as one of the 
leading causes of death in our nation. 
 
Mechanical signals have been identified to modulate signal transduction in vascular cells 
to alter gene expression5, 6 and cell function7.  In blood vessels, hemodynamic forces in 
the form of cyclic tensile strain and shear stress are known to regulate homeostasis8.  
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However, despite extensive progress in identifying the key intracellular signaling 
molecules that are modulated by mechanical strain, the mechanism of how cells process 
these mechanical signals and orchestrate physiologically relevant responses, remains 
unclear.  Understanding the role of mechanical cues in regulating vascular remodeling 
can lead to broad implications for tissue engineering and to developing therapeutic 
approaches to heart disease.   
 
1.2 Hypothesis 
The purpose of this work is to examine whether cyclic tensile strain can regulate 
autocrine and paracrine signaling of vascular cells to activate sequential stages of 
angiogenesis.   
 
1.3 Specific Aims 
1. Design and construct a mechanical strain device to be used for large scale 
assessment of vascular cell response to cyclic tensile strain. 
 
2. Investigate the mechanism by which cyclic tensile strain regulates endothelial 
cell phenotypes; selective cytokine secretion, migration and in vitro capillary 
formation, associated with angiogenic activation.  
 
3. Assess role of strain gradients in modulating recruitment of smooth muscle cells 




Current approaches to therapeutic angiogenesis primarily rely on the delivery of 
exogenous growth factors to regulate the development of engineered vasculature9, 
although limitations to this approach exists.  Mechanical signals are capable to regulate 
the development of various tissues10; but it remains unclear how cells can process these 
mechanical signals on the molecular scale to bring forth a physiologically relevant 
response.  This work examines whether modulating the mechanical environment of 
vascular cells may be sufficient to regulating angiogenesis via autocrine and paracrine 
signaling.  The quantitative effects of strain gradients on vascular activation and 
stabilization can provide parameters to model the local environment laying platform for 
future engineering approaches.   The devices, experimental methods and model systems 
developed here will enable further investigation and research into how mechanical cues 
that initiate at local scales can activate responses critical to formation of complex 
vascular networks.  The knowledge gained from this research can contribute to the 
current understanding of cues that regulate neovascularization to ultimately impact 
therapies for diseases associated with blood vessel dysfunction and this knowledge can 
also be translated to improved tissue engineering neovascularization strategies. 
 
1.5 Outline of Thesis 
A general overview of the current concepts and background that provide basis to this 
work is provided in Chapter 2.  Specifically, a review of the role of vascular remodeling 

















Figure 1.2:  Primary areas of research in tissue engineering 
Tissue engineering aims to repair or rebuild damaged tissues or organs.  Organs shown 
illustrate several focus areas in tissue engineering.  The underlying challenge remains 
development of an intact functional vasculature.  
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discussed.  In Chapter 3 (Aim 1), the design criteria, motivation and construction of 
S.M.A.R.T (a high precision mechanical strain device) along with characterization of 
materials will be presented.   These mechanical devices were used extensively for all 
cyclic strain experiments conducted in Chapter 4 and 5.  In Chapter 4 (Aim 2), the 
mechanism of cyclic strain activated in vitro angiogenic processes by endothelial cells 
was evaluated. Following this in Chapter 5 (Aim 3), we examined whether presentation 
of precise strain gradients can direct vascular cell migration in the context of 
angiogenesis.  Finally, Chapter 6 provides a critical analysis of results discussed in 

















1. Trends in the Health of Americans. CDC, 2006. 
2. Langer, R. & Vacanti, J.P. Tissue engineering. Science 260, 920-926 (1993). 
3. Gridelli, B. & Remuzzi, G. Strategies for making more organs available for 
transplantation. N Engl J Med 343, 404-410 (2000). 
4. Folkman, J. & D'Amore, P.A. Blood vessel formation: what is its molecular 
basis? Cell 87, 1153-1155 (1996). 
5. Chien, S., Li, S. & Shyy, Y.J. Effects of mechanical forces on signal transduction 
and gene expression in endothelial cells. Hypertension 31, 162-169 (1998). 
6. Oluwole, B.O., Du, W., Mills, I. & Sumpio, B.E. Gene regulation by mechanical 
forces. Endothelium 5, 85-93 (1997). 
7. Kakisis, J.D., Liapis, C.D. & Sumpio, B.E. Effects of cyclic strain on vascular 
cells. Endothelium 11, 17-28 (2004). 
8. Lehoux, S. & Tedgui, A. Cellular mechanics and gene expression in blood vessels. 
J Biomech 36, 631-643 (2003). 
9. Gibbons, G.H. & Dzau, V.J. Molecular therapies for vascular diseases. Science 
272, 689-693 (1996). 
10. Ingber, D.E. Mechanical signaling and the cellular response to extracellular 









REVIEW OF MECHANOTRANSDUCTION IN  
VASCULAR CELLS 
     
2.1 Introduction  
In order to motivate and provide background to understand the basis for the hypothesis 
guiding this thesis, this chapter will review the biology and role of endothelial cells in 
vascular remodeling, strategies to tissue engineer smooth muscle, and extracellular 
signaling via mechanotransduction.  Vascular remodeling is a complex process that 
occurs naturally during embryonic development and adult life.  Dysregulation of blood 
vessel formation however either leads or causes pathogenesis of many disorders.  The 
mechanisms known to activate endothelial cells during neovascularization will be 
reviewed.  Following this, an overview of tissue engineering smooth muscle will be 
presented.  This section will broadly discuss approaches to engineering smooth muscle, 
cell source, appropriate matrix, for engineering smooth muscle component in vascular 
grafts as well as in other physiologic tissues.   In conclusion, a review of 
mechanotransduction will be presented, highlighting the signaling transductions 
pathways that govern this process in both endothelial cells and smooth muscle cells. 
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2.2 Role of Endothelial Cells in Vascular Remodeling  
The vasculature is an active organ that responds to local cues of growth factors1-4 
intercellular communications5, 6, vasoactive substances7, and hemodynamic stimuli8-10, by 
altering the structure of preexisting vessels in order to deliver nutrients and gas exchange 
to tissues in our body.  The formation of these blood vessels is mediated by distinct 
cellular processes that integrate endothelial, smooth muscle, and fibroblast cells into a 
vessel wall.  Neovascularization is governed by two primary mechanisms: vasculogenesis 
and angiogenesis11, 12 (Figure 2.1).  In brief, vasculogenesis occurs during the 
development of the embryo when the early vascular plexus forms from the mesoderm to 
generate primitive blood vessels13.  Angiogenesis, a mechanism that occurs both during 
development and in adult life, encompasses the remodeling of preexisting vessels that are 
sprouting as well as those that are non-sprouting11.  As delineated in Chapter 1, this thesis 
will focus on the latter process; where we will review the role of endothelial cells during 
neovascularization.  Remodeling of the vasculature is a natural biologic process and 
occurs during the adult life in the reproductive organs or during pathological conditions 
of tumorigenesis, inflammation, or vascular diseases14.  
 
Reorganization of the vascular network is activated by a range of stimuli from the local 
environment, hemodynamic conditions or circulating factors.  These signals are 
subsequently transduced, via the extracellular matrix that supports the endothelial lining 




Figure 2.1:  Mechanisms of blood vessel formation 
Two mechanisms of blood vessel formation differentiated primarily by the cells source 
initiating the process.  Vasculogenesis develops the vascular plexus, connecting the 
cardiovascular system to all tissues.  Angiogenesis requires a sequence of events, 
activated by endothelial cell migration, differentiation, and concluding with stabilization 
by pericytes or smooth muscle cells. (Image adapted from Gerwins et al.12) 
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existing vessels.  The endothelium is therefore a critical component of the remodeling 
process as it interfaces with blood flow and is exposed to direct contact with mechanical 
forces, inflammatory cytokines, and other circulating factors.  Endothelial cells have been 
implicated to transduce chemical as well as mechanical signals15. 
 
Angiogenesis is defined as the formation of new capillaries from existing blood vessels 
via sprouting.  Prior to neovessel outgrowth, proteolytic degradation, via matrix 
metalloptoteinases16 or plasminogen activators, of local extracellular matrix provides the 
necessary space for vascular reorganization.  This is followed by migration and 
proliferating of endothelial cells to coalesce and form capillary structures.  Endothelial 
cells participate directly in vascular remodeling by releasing or activating substances to 
influence the proliferation, migration of other cells or reorganization of the extracellular 
matrix.  The factors that regulate endothelial cells in vascular remodeling involve VEGF-
A17, 18, angiopoietins and their respective Tie receptors2, 5, 6, 19-24 as well as several 
extracellular matrix components.  Hypoxia has also been found to induce expression or 
secretion of angiogenic molecules25.   The endothelium is exposed to fluid forces, and the 
effects relayed by changes in blood flow generate a range of stresses26, 27 on the 
endothelial surface, known to activate vascular remodeling.  The capacity of the 
endothelium to sense mechanical signals is therefore an important determinant of 
vascular structure.  Biochemical mitogenic factors along with appropriate mechanical 
signals clearly regulate the neovascularization process, which relies on a precise 
orchestrated spatio-temporal presentation of cues to activate sequential stages of the 
vascular development.  
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2.3 Tissue Engineering of Smooth Muscle 
Smooth muscle cells play an important role not only during the initial sprouting in 
vascular remodeling, but also for the stabilization and maturation of the vasculature.  
Functional vascular networks rely on its capability to allow blood perfusion28.  This 
section will provide an overview of engineering smooth muscle in a broad context, 
extending beyond its role in the cardiovascular system. 
 
Smooth Muscle Cell Source 
A critical question in the engineering of smooth muscle tissues is the appropriate source 
of the SMCs that will comprise the tissue.  The majority of research to date has utilized 
smooth muscle procured from the tissue of interest.  However, the isolation of smooth 
muscle progenitors may allow for a less invasive and destructive approach.  In addition, it 
may be possible to directly recruit SMCs to the site at which one wants a tissue to form.  
 
The most direct approach to form smooth muscle tissues is to utilize smooth muscle cells 
obtained from the tissue one desires to engineer.  In this approach, smooth muscle 
containing tissue is typically explanted and dissociated into individual cells.  The cells are 
then directly transplanted or expanded in culture, and subsequently transplanted.  Direct 
transplantation may be advantageous as it bypasses in vitro culturing, which can alter the 
contractile phenotype of smooth muscle cells.  In contrast, culture of smooth muscle cells 
prior to transplantation may lead to phenotypic changes 29, 30, but this approach allows 
one to greatly expand the cell population.  This may allow a relatively small explant to 
ultimately yield sufficient cells to engineer a large tissue.  The phenotypic changes noted 
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in smooth muscle cells, as they revert to a synthetic phenotype 31 may be reversed or 
prevented through appropriate culture conditions (i.e. cyclic mechanical loading) 32.   
 
While smooth muscle tissues characteristically contain contractile apparatus and form the 
muscular components of visceral structures, there are differences between SM in various 
tissues 33.  These likely relate to the specific microenvironment and physiology of each 
tissue type.  For this reason, SM biopsies are typically procured for the specific type of 
tissue being engineered.  The artery is the most commonly excised tissue for vascular 
regeneration 34-37 primarily because it is the largest blood vessel, and hence contains the 
thickest medial layer.  Current methods for bladder replacement require a biopsy to 
obtain a small specimen of the donor or host bladder tissue, which is then used to expand 
separate cultures of urothelial and smooth muscle cells 38.  Ureter or renal pelvis cells can 
be similarly harvested.  Regeneration of gastrointestinal organs, specifically the stomach 
and the intestine, has most commonly utilized organoid units which contain smooth 
muscle precursors 39, 40. 
 
Differentiated smooth muscle cells have shown tremendous utility for the successful 
regeneration of smooth muscle tissues.  However the invasive nature of this cell 
procurement, the inherent limited proliferation capability of primary cells, and 
maintenance of smooth muscle phenotype are all limitations to this cell source. 
Smooth muscle progenitors may potentially be isolated using minimally invasive 
techniques, and subsequently induced to differentiate down a smooth muscle lineage.  
Cells isolated from bone marrow are termed bone marrow stromal cells (BMSC), or 
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mesenchymal stem cells (MSC) depending on the mode of cell purification selection in 
vitro.   
 
Bone marrow can be obtained easily from the medullary canals of long bones or the 
cancellous cavities 41, and the resultant BMSC can be readily expanded in culture.  
BMSCs have demonstrated the ability to differentiate into multiple mesenchymal cell 
lineages, and offer an alternative source of smooth muscle cells 33, 42-49.  Recent studies 
have shown that BMSCs are inducible down a smooth muscle pathway, and this process 
is regulated by an interplay between stimulatory molecules 50, 51, with TGF-β and PDGF 
as the main modulators (Dennis and Charbord 2002).  Mechanical stimulation has also 
been shown to effect differentiation of bone marrow stromal cells 52.  However, the 
mechanism of this effect is still unclear.    Smooth muscle progenitors can also be derived 
from embryonic stem cells 28, 53, circulating blood 54, 55, bone marrow 56, 57 and other 
tissues 58.  
 
The recruitment of SMCs or progenitors from a surrounding tissue to an engineered 
tissue provides an alternative to SM transplantation.  Signaling molecules such as PDGF  
and TGF-β have chemotactic effects on smooth muscle cells 59, and growth factors  
released by endothelial cells (ECs) can also induce the migration of mesenchymal stem 
cells and their subsequent differentiation into smooth muscle like cells 60, 61.  Similarly, 
myoblast recruitment can be modulated by a gradient of a chemotactic agent 62.  This 
recruitment approach greatly simplifies the process of smooth muscle tissue engineering, 
as it eliminates the isolation and expansion of cells in vitro.  In addition, this approach 
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could have utility in applications such as blood vessel repair where direct placement of 
smooth cells in the lumen could cause a thrombogenic effect.  The use of signaling 




Tissue engineering utilizes synthetic extracellular matrices to provide an infrastructure 
for the formation of tissues by providing a predefined space to localize tissue growth and 
the mechanical support necessary to facilitate this growth.  Synthetic extracellular 
matrices (ECM) may also provide specific signals to the SMCs.  Two general designs of 
synthetic extracellular matrices for smooth muscle tissue regeneration are being pursued, 
one involving a biological approach where the matrix is assembled by the resident cells 
and the other utilizing predefined polymeric structures. 
 
SMCs maintained for extended times in culture will synthesize, secrete, and assemble an 
ECM with sufficient mechanical integrity to allow a sheet of confluent SMCs to be 
manipulated and formed into a three dimensional tissue 63.  This technique is attractive 
for tissue engineering because it eliminates the need for exogenous biomaterials, and 
thereby eradicates any potential inflammatory issues related to the material 64, 65.  Self 
assembly approaches have focused on engineering vascular grafts by individually 
culturing cellular sheets to model the defined layers of the blood vessel.  A sheet of 
smooth muscle cells is used to form the medial layer, which is subsequently wrapped 
with a sheet composed of fibroblasts to form the adventitial layer, and finally seeded with 
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endothelial cells to create the lumen.  Initial studies on tissues formed utilizing this 
approach reported poor mechanical strength 66, 67, which is indicative of a deficient 
medial and, or adventitial layers.  A revised approach increased the mechanical strength 
of tissues formed with this approach 63.  However, a limitation to this approach is the 
extensive time required to form the cellular sheets.   
 
Most approaches to engineer SM tissues have utilized three dimensional, biodegradable 
polymeric scaffolds.  Polymeric scaffolds formed from exogenous biomaterials provide 
mechanical stability and can deliver signaling molecules or adhesion peptides to induce 
appropriate tissue development.  These polymeric biomaterials are fabricated from either 
synthetic or naturally derived materials.  Synthetic polymers typically used for 
engineering smooth muscle tissues include several forms of polyesters, elastomeric 
polymers, and hydrogels.  The most common used naturally derived polymer used to 
engineer SMC is type I collagen. 
 
The most prevalent synthetic polymers used to engineer smooth muscle tissues are the 
polyesters poly(glycolic acid) (PGA) (Fig. 2a), poly(L-lactic acid) (PLLA), and poly 
(lactic-co-glycolic acid) (PLGA).  Advantageous features of these polymers include their 
reproducible and readily altered mechanical properties and degradation rates 68, 69.  These 
polymer scaffolds provide temporary mechanical support 70 sufficient to resist cellular 
contractile forces in vitro 71-74, and scaffolds exhibiting partial elastic properties under 
cyclic strain enabled induction of a more contractile, differentiated smooth muscle 
phenotype from attached SMCs 75.  In addition to structural stability, appropriate signals 
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may be required to guide the development of smooth muscle tissues.  Synthetic polymers 
can be modified to incorporate signals to alter cellular function, including cell adhesion 
molecules 76-78 and growth factors 79, 80.  
 
Hydrogel forming polymers have also been investigated for engineering SM tissues.  
Polyethylene glycol (PEG) hydrogels intrinsically resist protein adsorption and cell 
adhesion 81 and this characteristic offers advantages for studying the effects of specific 
bioactive ligands or peptides presented from the scaffold 82, 83.  Studies utilizing surface 
modified PEGs have demonstrated that a number of cellular functions, including 
adhesion 82, migration 84, and matrix production 85 can be regulated by ligand 
presentation.  In general, hydrogels are an appealing scaffold material because they are 
structurally similar to the highly hydrated extracellular matrix of many tissues 86.  
However, the use of hydrogels is often constrained by their limited range of mechanical 
properties. 
 
The elasticity provided by elastin in SM tissues has motivated the development of 
elastomeric scaffolds that can similarly provide this property to engineered SM.  
Elastomeric polymers can recover from extensive deformation 87-89 and are designed to 
resemble the incompressible nature of the ECM 90.  This property of biomaterials may be 
ideal to engineer functional SM tissues that require transduction of mechanical signals 
from the extracellular environment in order to elicit and activate key cellular functions 91-
93.  This type of biomaterial resolves the limitations of lack of pliancy that limits many 
synthetic polymer scaffolds (i.e., poly(lactic acid) (PLA)). 
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Type I collagen (Fig. 2b) has been frequently used to create polymer scaffolds for 
engineering SM tissues 71, 75, 94, 95.  Naturally derived collagen is an attractive biologic 
material because collagen is the primary constituent of the ECM 96, and contains adhesion 
ligands that facilitate cell attachment.  Although type I collagen does not require 
additional surface modification to promote tissue formation, glycosaminoglycans (GAGs) 
97 and growth factors 98 can be incorporated to improve mechanical properties and to 
induce specific cellular functions.  Type I collagen matrices used to engineer SM tissues 
have demonstrated partial elasticity and are capable of withstanding cyclic stain 75.  The 
high tensile strength of type I collagen can be attributed to its molecular structure, while 
the elasticity is conferred by the intermolecular cross-linking.  The degradation of type I 
collagen scaffolds is dependent on the extent of cross-linking, pore structure and the 
apparent density, which are variables that can be readily altered to meet a desired target.  
Although type I collagen is typically extracted from xenogeneic sources, it is considered 
biocompatible and exhibits low immunogenic responses, likely due to the similarity of 
this molecule between species 99.  However, naturally derived materials may suffer from 
batch to batch variations. 
 
Another collagen based biomaterial, small intestinal submucosa (SIS), has also been 
widely used in tissue engineering research 100-102.  This xenogeneic matrix is harvested 
from the submucosal layer of the intestine.  SIS may provide functional growth factors 103 
that contribute to SM tissue formation.  In addition, SIS matrices maintain elasticity and 
high strength 104.  SIS has typically been obtained from porcine sources, but isolation 
from rats 105 and canines 106 has also been attempted.  SIS has been used to promote 
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regeneration of several SM tissues, in the blood vessels 107, 108 and in the bladder 104, 106, 
109.   
 
Engineered Smooth Muscle Tissues 
A number of studies to date have utilized a combination of scaffolding technologies and 
cells to reconstruct the smooth muscle component of cardiovascular, gastrointestinal and 
urinary tissues.  The two primary tissue engineering approaches used to regenerate tissues 
are cell transplantation and cell recruitment from surrounding tissue.  Cell transplantation 
requires an initial step of procuring cells, often via biopsy from the host, followed by 
dissociation and expansion in vitro.  The cells are then seeded onto a scaffold and 
implanted as a cell-matrix construct.  Alternatively, an implanted acellular matrix may be 
implanted to promote the recruitment of neighboring SMCs and possibly other cell types 
of interest (e.g., ECs, urothelial cells).  Work to date in engineering SM tissues is briefly 
summarized in this section.   
 
A great deal of research has been performed with the goal of developing blood vessel 
substitutes, due to the large impact this advance would have on the millions of patients 
that annually suffer from diseases of  blood vessels 110.  Strategies to engineer blood 
vessel must provide adequate mechanical properties, to avoid catastrophic failure in this 
mechanically demanding site, and appropriate cellular components to form the complex 
vascular wall.  An early approach to engineer the blood vessels involved the culture of 
different vascular cell populations in collagen gels to form three distinct layers, 
resembling the three layers of native blood vessel 66.  However, this model did not lead to 
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tissues with adequate mechanical strength.  A later approach exploited the ability of 
fibroblasts and SM cells to synthesize and secrete their own ECM and form self 
assembled sheets.  These sheets were subsequently wrapped around a mandrel to form 
distinct layers of the native vessels 63.  This method led to tissues with much greater 
mechanical strength, comparable to that of human vessels 67.  The increased mechanical 
strength of these tissues my be partially attributed to paracrine effects between ECs and 
SMCs 5, 60, 111 that contribute to the stability of nascent blood vessels by increasing matrix 
production.  Also, implantation of a decellularized SIS with additional type I bovine 
collagen into a rabbit artery led to the formation of a blood vessel characterized by 
reasonable burst strength, cell and matrix organization 107.   
 
Several groups have utilized externally applied mechanical stimulation to improve the 
mechanical integrity of engineered SM tissues (Fig. 4b).  Blood vessel substitutes formed 
from allogeneic vascular SMCs and ECs cultured on biodegradable PGA scaffolds were 
maintained under pulsatile stress, and this resulted in an increased matrix production 112.  
These engineered constructs were subsequently implanted into swine for seven weeks 
and the explanted vessels exhibited adequate burst pressures and histology.  Several 
studies document that one can improve the properties of constructs engineered using 
collagen through  the use of mechanical stimulation 113, 114.  The significance of 
mechanical stimulation was also demonstrated by studies where synthetic SMCs cultured 
with ECs on collagen gels were found to undergo a phenotypic reversion under 
contractile forces 31, 115.   
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2.4 Mechanotransduction and Extracellular Signaling 
Blood vessels are physiologically exposed to hemodynamic forces in the form of cyclic 
tensile strain and shear stress due to the pulsatile nature of blood flow.  Vascular 
endothelial and smooth muscle cells are exposed to both types of mechanical forces, 
where predominantly only endothelial cells are subject to shear stress.  Extensive 
research demonstrates that mechanical signals modulate cell functions of vascular 
endothelial116 and smooth muscle cells91-93.  This section will review the mechanosensors 
on vascular endothelial and smooth muscle cell membranes used to detect signals.  This 
is followed by a comprehensive overview of the various intracellular signaling pathways, 
where an enormous number of studies have documented signaling molecules implicated 
responsive to mechanical stimuli.  A brief review of chemical signals is discussed at the 
end, as vascular remodeling is likely a process involving the interplay of extracellular 
signals.  
 
Endothelial cells (ECs) act as mechanosensors and detect changes in the mechanical 
environment through various sensing mechanisms.  Intracellular signaling pathways have 
been documented to initiate via cell adhesion molecules (CAMs), receptor tyrosine 
kinases (RTKs), ion channels, and G-protein coupled receptors (GPCRs), and likely, the 
interplay of these sensing mechanisms.   
 
Mechanosensors: cell adhesion molecules (CAMs) 
Integrins (a member of the heterophilic CAM subfamily), link the immunoglobulin 
superfamily or the extracellular matrix (ECM) to the cell cytoskeleton117 and provide for 
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a method to anchor the cell to the substratum or to other cells.  Integrins are composed of 
transmembrane α and β subunits that simultaneously bind to extracellular proteins 
(collagen, fibronectin, and laminin) and intracellular anchor proteins at focal adhesion 
sites e.g. focal adhesion kinase (FAK) and c-Src, and cytoskeletal proteins e.g., talin, a-
activin, filamin, vinculin, via the cytoplasmic tail of the β subunit 96.  The intracellular 
proteins at focal contacts can directly link to the cytoskeleton by binding to actin 
filaments and through this, provide a bridge by which mechanical strain can be 
transduced from the ECM to the cytoskeleton.  Cyclic strain modulates the directional 
organization of EC integrins118, 119 cultured on surfaces treated with fibronectin and 
collagen.  Reorganization of integrins resulting in clustering, activates tyrosine 
phosphorylation120, 121 to initiate downstream signaling pathways.  Exposure of ECs to 
shear stress induce clustering122, 123 of integrins, association with adaptor proteins122 and 
activation of focal adhesion kinases123.  Recent studies suggest that integrins can 
associate with adaptor proteins that link to transmembrane growth factor receptors 
(GFRs) 124, where a majority are receptor tyrosine kinases (RTKs).  Cyclic mechanical 
strain of SMCs increases levels of focal contact components 125, integrin clustering 124, 
and provide a potential mechanism for the role of mechanical signals in activation of 
FAKs.  Shear stress has been documented to enhance the expression of several 
immunoglobulin superfamily, primarily PECAM-1126, 127, a molecule located at the 
junction sites of confluent EC monolayers, ICAM-1128 and VCAM129, 130, intercellular 
molecules linking ECs to SMCs.  
 
Mechanosensors: RTK (receptor tyrosine kinases)  
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Receptor tyrosine kinases (RTKs) include a transmembrane spanning domain, an 
extracellular N-terminal region and an intracellular C-terminal region. The extracellular 
N-terminal region is composed of large protein domains that bind to extracellular ligands 
while the intracellular C-terminal region is primarily responsible for signal transduction 
and kinase activity.  Shear stress have been demonstrated to activate VEGF receptor, Flk-
1122, of ECs, independent of VEGF ligand binding131.  While Tie-2, an endothelial cell 
specific receptor to ligand Angiopoietin 1 and 2, was also shown to upregulate in 
response to shear forces.  Cyclic strain has been shown to stimulate tyrosine 
phosphorylation of PDGFR-α132 and increase PDGR-β in aortic SMCs133.   
 
Modulation of signaling pathways 
Cyclic strain and shear stress can activate a number of mechanosensors that result in 
activation and propagation of signals through a network of pathways.  A great deal of 
research has reported the activation of multiple signaling molecules in response to 
mechanical signals, including FAK, Rho family GTPases, PI3K, protein kinase C (PKC), 
Notch, and most widely studied, MAPKs.  Signaling via Akt in response to shear stress 
has been implicated to maintain endothelial survival and integrity in blood vessels134, a 
downstream target of Phosphoinositide 3-kinases (PI3K)135, also known to exhibit 
enhanced activation in response to cyclic strain.  Exposure of SMCs to cyclic strain also 
induces the phosphorylation and activation of pro-survival Akt protein kinase136, and ECs 
exposed to shear stress similarly exhibit activation of the Akt pathway137.  Akt is 
activated in response to a number of growth factor stimuli, including PDGF, VEGF, EGF, 
insulin, and thrombin in ECs138, 139 and has been implicated in cell functions such as 
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proliferation and anti-apoptosis.  Rho family GTPases serve as convergence points for 
actin cytoskeleton signals and acts as molecular switches to control cellular processes.  
The Rho family members, Cdc42, Rac, and Rho have different functions in regulating the 
actin cytoskeleton structure and intracellular singaling.  Shear stress has been shown to 
induce a transient activation of Cdc42140, while sustained activation140 and decreased 
activity of RhoA141 have both been documented.  Generally, Cdc42 and Rac regulates 
filopodia and lamellipoida formation, while RhoA increases cell contractility142.  
Mitogen-activated protein kinases (MAPKs) are a group of serine/threonine kinases that 
activate in response to dual phosphorylation at conserved threonine and tyrosine residues 
to extracellular stimuli and regulate various cellular functions.  There are 3 distinct 
MAPK modules in mammalian cells, the extracellular signal regulated protein kinases 1 
and 2 (ERK1/2) 143, 144, the JNK/SAPK145, and the p38146 pathways, where activation of 
these molecules in ECs have been reported in response to cyclic strain.  However, the 
cyclic strain induced activation of JNK in SMCs has been documented to be integrin 
independent, occurring in cultures treated with pronectin and laminin147.  Protein kinase 
C (PKC) is a crucial serine/threonine kinase that is co-activated by membrane bound 
diacylglycerols (DAG) and Ca2+ and phopholipid phosphatidylserine at the plasma 
membrane148.  PKC is known to activate various target proteins to alter cellular function 
and exposure of vascular endothelial and smooth muscle cells to cyclic strain leads to 
activation of the PKC pathway149-151.  Focal adhesion kinase (FAK) binds to the cytosolic 
tail of one of the integrin subunits and can cross phosphorylate when triggered by integrin 
clustering and documented above to reorganize in response to mechanical stimuli.  
Recent studies have also shown that cyclic strain can mediate the upregulation of 
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Notch152, a signaling pathway important for neuronal development and endothelial fate in 
angiogenesis.   
 
Mechanical signal effects of cell function 
Mechanical forces regulate a number of physiologic tissues that are normally exposed to 
loading or compressive forces.  Extensive studies have been conducted on a number of 
cell and tissue types to investigate regulatory effects by mechanical stimuli.  Several 
tissues commonly reported to respond to mechanical forces is listed here, whereas more 
relevant literature on vascular remodeling is discussed within each specific aim of this 
thesis.  Cyclic uniaxial loading has been reported to regulate vascular endothelial cell 
patterning153, skeletal muscle growth154, osteogenic growth155, 156, cardiomyocyte 
contractility157, and extracellular matrix production158-160.  Early studies focused largely 
on bone and found that physical strain held a role in regulating differentiation 161, 162, 
remodeling163, 164 and regenerative of bone tissue.  Application of biaxial strain have been 
reported to enhance smooth muscle development75, 93 and organization165, activate 
endothelial cell gene expression116, osteogenic differentiation32, 166, and cell adhesion125.   
 
Extracellular Signaling: paracrine, autocrine signaling and vascular mitogens  
Several mechanisms exist to enable one cell to influence the behavior of other cells via 
extracellular signal molecules.  Contact dependent (Figure 2.2A) signaling occur when 
signaling molecules remain bound to the signaling cell surface and influence only other 
cells that come in direct contact with the signaling cell (e.g. PECAM/CD31 expressed on 
EC membranes regulate adhesion with to other ECs and activate downstream signaling 
 27
pathways when bound)167.  However, most signaling molecules are secreted.  Paracrine 
signaling (Figure 2.2B) occurs when secreted molecules act as local mediators and affect 
only cells in the immediate environment of the signaling cell.  Paracrine signaling 
molecules are often rapidly taken up target cells, or degraded over large distances (e.g. 
PDGF secreted by ECs to induce chemotactic effects on SMCs168, 169). 
 
Cells can also send signals to self regulate via autocrine signaling (Figure 2.2C).  This 
process occurs when a cell secretes signaling molecules into the local environment to 
bind to the surface receptors of cells identical to the original signaling cell. This signaling 
mechanism is particularly prevalent during embryogenesis to reinforce a developmental 
decision (e.g. after a cell has initiated differentiation down a specific path).  Autocrine 
signaling is most effective when performed simultaneously by neighboring cells of the 
same type (e.g. Angiopoietin 2 secreted by ECs)22, 23, 170, and it is likely to be used to self 
activate a group of cells to perform a concerted response. Thus, autocrine signaling is 
thought to be one possible mechanism underlying the community effect that is observed 
in early development, during which a group of identical cells can respond to a 
differentiation-inducing signal but a single isolated cell of the same type cannot96.  Many 
diseased states similarly utilize autocrine signaling to overcome the normal controls on 
cell proliferation and survival. By secreting signals that act back on the cell's own 
receptors, autocrine signaling allows cancer cells to activate anti-apoptotic pathways171 in 






Figure 2.2A-C Mechanisms of Extracellular Signaling 
(A) Contact-dependent signaling requires cells to be in direct membrane contact. (B) 
Paracrine signaling relies on signaling molecules secreted by one cell into the 
extracellular space to effect local target cells.  (C) Autocrine signaling is a mechanism by 
which one cells secretes signaling molecules into the extracellular space to return and 
bind to its own surface receptors, essentially acting as a positive feedback regulator. 




The extracellular environment scaffolds and serves as a temporary holding ground for 
these autocrine and paracrine that play a pivotal role in vascular remodeling by providing 
instructions to endothelial and smooth muscle cells.  Mitogenic factors have shown to 
possess a significant effect on of both endothelial cells and smooth muscle cells in culture 
include vascular endothelial growth factor (VEGF), angiopoietins (ANG), platelet 
derived growth factor (PDGF), transforming growth factor-β (TGF-β), and to a lesser 
extent, heparin binding-epidermal growth  factor (HB-EGF) and fibroblast growth factor-
2 (FGF-2) 5, 172.  PDGF has been shown to have potent effects on proliferation, migration, 
and matrix production by smooth muscle cells 28, 53, 59, 60, 62, 92, 173, 174.  An increase in the 
synthesis of SM extracellular proteins is stimulated by TGF-β and these matrix 
components provide mechanical integrity to engineered smooth muscle tissues 59, 61, 85, 98, 
175-178.  Particularly in strategies where smooth muscle recruitment is important, 
angiopoietin and HB-EGF have both shown to mediate endothelial and smooth muscle 
cell interactions 5, 20, 111, 179.  However, SM tissue engineering strategies that utilize 
growth factors must consider the mode of delivery.  Polymeric encapsulation of growth 
factors is a common approach to deliver the molecules to the developing smooth muscle 
tissues in a controlled and sustained manner 180.  
 
2.5 Summary 
Vascular remodeling is a process critical to tissue engineering and for developing 
therapies associated with neovascularization.  Cytokines, circulating factors and 
hemodynamic stimuli play a key role in this process due to their ability to direct the 
activation of the endothelial cells that line the endothelium.  Equally important is to 
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understand the cues that regulate the recruitment of smooth muscle cells to neovessels 
and approaches to engineer smooth muscle in culture, in order to develop stable mature 
vascular networks.  Understanding how these vascular cells together are regulated by 
local mechanical stimuli together with biochemical cues would enable improved 
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DESIGN AND CONSTRUCTION OF A COMPUTER CONTROLLED  
STRAIN MECHANICS ASSESSING RESEARCH TOOL (SMART) 
 
3.1 Introduction  
In order to address the hypothesis that cyclic strain can play a role in regulating vascular 
cells during angiogenic activation, I needed to develop a strain device that allowed me to 
systematically assess strain effects at high precision and in a higher throughput method.  
This new device was designed to deliver uniaxial tensile strain, as it is most 
physiologically relevant to the forces experienced by vascular cells that comprise the 
walls of blood vessels during cyclic distension caused by blood flow.   
 
Cells throughout our body are exposed to various forms of mechanical stimuli.   Studies 
have reported that mechanical stretch signals play a role in maintaining homeostasis in 
vascular tissues1, 2.  Long bones of the musculoskeletal system undergo compressive 
loading from vertical impact, as opposed to the tensile forces translated through skeletal 
muscles to which they are connected3.  The respiratory system, lined by epithelial cells4, 
experiences tensile forces purely through the mechanics of breathing, similar to 
gastrointestinal tissues which expand cyclically due to peristaltic movement.  Healthy 
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tissues under normal function are capable to withstand persistent loads, but the question 
remains whether mechanical signals can alone regulate cell processes.  The desire to 
replicate these signals in order to understand the mechanisms that underlie cellular 
responses to strain has led to the development of numerous mechanical strain devices 
used for in vitro studies.   
 
To date, the majority of in vitro mechanostimulatory devices used to examine effects of 
mechanical cyclic strain on vascular cells mainly focus on the use of uniaxial and biaxial 
tensile applications.  The fundamental difference between uniaxial and biaxial tensile 
strain resides in the boundary conditions that characterize each strain regime. Several 
types of biaxial strain devices have been developed, and the methods of force application 
range from use of a dynamic indenter5 to using vacuum pressures (both positive6 or 
negative7, 8) to stretch the bottom surface of the elastic substrate to which the cells are 
cultured.   One main advantage of using biaxial strain devices is the availability of 
commercial devices (Flexercell machine9) and associated consumables for experimental 
operations.  However, most biaxial strain devices present non homogeneous strain fields 
within each culture surface8, where a radial strain gradient is introduced from the source 
of strain.  However, a region of equi-biaxial stretch exists in the center10, 11 of each well.  
A number of custom uniaxial strain devices have been developed to examine cells that 
are normally exposed to lateral stresses12-16.  However, a limitation of most uniaxial strain 
devices is the capability to assess only a the limited number of samples11, 13-16 at one time.  
Most devices also lack the platform to perform consistent clamping and loading of 
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samples, which can significantly alter substrate strain13, 14, 17 and ultimately, introduce 
large variations between experiments.  
 
Presented here are the design criterions for several devices: a novel large scale uniaxial 
Strain Mechanics Assessing Research Tool (S.M.A.R.T), a mini S.M.A.R.T. for 
microscope image documentation, and custom elastomeric culture plates designed 
specifically for these strain devices. The design criteria of each are listed as follows: 
Design Criteria of large scale S.M.A.R.T. 
• simultaneously strain 48 wells (12 conditions, n = 4) 
• programmable strain regimen via a computer interface (amplitude, frequency, and 
or alternations with time) 
• precision application of repeatable cyclic strain (repeatability and error ~1um) 
• each condition capable to be individually loaded and removed  
• strains 2D and 3D materials 
• entire device able to be dismantled and parts autoclavable 
• device construction material: strong, light, does not pit, wear. 
Design Criteria of mini S.M.A.R.T. 
• Easily loads device clamps from large scale S.M.A.R.T.  
• Fits onto inverted microscope (Olympus IX81) stage for image documentation 
and live cell imaging.   
Design Criteria of Device Clamps 
• Alignment marker for consistent clamping locale to PDMS plates. 
• Allows individual culture of each condition and ease of loading onto device. 
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Design Criteria of Elastomeric culture wells (PDMS) 
• Surface area for culture adaptable to various sizes: 1cm2, 5cm2, 35cm2 
• 2D plates : homogeneous strain and adaptable to create strain gradients  
• 2D plates:  4 wells per plate (for statistical analysis) 
• 2D plates : mold contains alignment holes for consistent clamping 
• 2D plates : walls reinforced at based to secure attachment 
• 3D plates:  homogeneous strain and adaptable to create strain gradients  
• 3D plates:  adaptable for microfluidic delivery of drugs 
 
3.2 Materials and Methods  
Design of S.M.A.R.T 
The design chart of operating the large scale S.M.A.R.T. (Figure 3.1) consists of a linear 
motor (Newmark, Mission Viejo, CA), a NSC stepper motor controller (Newmark, 
Mission Viejo, CA) with an open loop feedback, a power supply, and a computer 
interface.  The computer interfaces with the controller to communicate input values of 
displacement, frequency, and length of run time.  The SMART apparatus consists of 
several main components:  The linear motor, the moving stage, stationary stage, the base, 
and the device cover (Figure 3.2A-B). 
 
Principle of Straining 
The apparatus is designed to apply a dynamic uniaxial stretch to a maximum of 48 
elastomeric wells (12 conditions) simultaneously.  The principle of strain applied to each 
















Figure 3.1:  Design chart of S.M.A.R.T system 
The device is regulated by a controller that is programmable using a computer inter to 















Power requirement for the linear motor was assessed in order to select an appropriate 
linear motor.  The minimum motor power required to strain the maximum load of 12 
PDMS plates was determined using an Instron material tester (Instron, Norwood, MA).  
The force required to stretch one PDMS well to 110% was measured and scaled up (by 
48 wells) to measure the minimum total force required to distend all plates by 10% strain. 
 
Moving and Stationary stage platform and alignment bar 
The moving plate (15” x 3.9”) was constructed using a 0.375” thick Aluminum plate.  
The plate was positioned by placing the longer side perpendicular to the direction of 
strain in order to allow loading of numerous samples.  The moving plate had 4 tapped 
holes in the center to allow fixture to the linear motor using screws.  The edge of the plate 
(along 15” side) had 8 blind holes to allow insertion of 8 alignment pins.  Alignment pins  
were inserted along the edge of both the moving plate and the stationary plate in order to 
precisely but quickly fasten 4 sets of PDMS clamps (2 alignment pins per each side of 
clamp).   
 
The stationary plate was constructed using a 0.75” thick Aluminum plate, and stood at a 
height of 2.159” over the linear motor device.  The stationary plate had 4 tapped holes on  
the side in order to fix 2 support knees, an added design to eliminate any possible 
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Figure 3.2A-C:  Large scale S.M.A.R.T. device and principle of straining 
 (A) Photograph of completed S.M.A.R.T.  Shown loaded are 4 sets of PDMS plates, (16 
wells). (B) 3D render of AUTOCAD design of large scale S.M.A.R.T.  Shown here is the 
device with a Lexan cover over the strain device to provide a contained sterile 
environment. (C) A cross sectional view of a PDMS well where device clamps are shown 
on the left and right immediate exterior of the PDMS well, along with the direction of 






torquing caused by strain forces applied on the PDMS plates that may cause arching of 
the standing stationary plate.  Finally, the stationary plate had 8 blind holes on the top 
face, for the aforementioned alignment pins.  Along the furthest edge of the moving and 
stationary plates, 2 long (4” threaded) rods protruded to fix a master alignment bar.  This 
alignment bar was to secure all PDMS clamps maintained seated and to eliminate any 
torquing movements, to ultimately ensure that samples on the third level experienced 
equal strain as samples on the bottom, first level. 
 
SMART base plate and Lexan cover 
The base plate (18” x 18”) was constructed of a 0.38” Aluminum plate, capable to 
withstand a minimum of 40lbs, exceeding the weight of all device components.  The 
bottom surface of the base was tapped with 4 holes to attach leveling mounts with 
dampening pads onto the device which serve two purposes (1) to dampen any vibrational 
motion to not affect other cell cultures in the incubator and (2) to allow easy lifting of 
device off other metal surfaces (in incubator).  The top surface of the base was tapped 
with 14 tapped holes (4 screws to fix the linear motor, 2 screws to fix the stationary stage 
platform, 2 screws to fix the support beam to the stationary stage platform, and finally 6 
screws to fix three handles to lift device).  A method to enclose the straining samples 
from the surrounding incubator environment was developed by designing a Lexan cover, 
machined (Altec Plastics, MA) with dimensions: (12 x 13 x 8) in3.  The material, 
polycarbonate lexan was selected for its temperature resistance (up to T=250oF), and 
therefore would be autoclavable.  In order to secure a location for placement of the Lexan 
cover, a groove was machined into the base plate to enclose cell culture samples, as well 
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as a portion of the linear motor.  However, in order to allow gas exchange into the cell 
cultures (region enclosed by the lexan cover), it was necessary to develop a 2 step groove.  
In order to achieve this, a region at the 4 corners was machined by only 0.13” (where the 
lexan cover would sit within the groove, however slightly lifted), while the entire 
perimeter was machined to a deeper 0.25” groove (to allow gas exchange into the cell 
culture strain area). The entire base plate, constructed of Aluminum was anodized to 
avoid pitting over continuous use. 
 
Design of mini S.M.A.R.T 
The mini SMART is a small scale strain device that loads 2 PDMS plates (one for strain 
application and one for non strained culture) and designed to fit precisely onto an 
inverted microscope stage (Olympus IX81).  This device was designed to supplement the 
large scale SMART device and serves three main purposes: (1) for quick, high resolution, 
image documentation of cultures removed temporarily from the large scale SMART, (2) 
for live cell imaging of cells under strained conditions and (3) for 2D or 3D material 
characterization in response to strain.  The strained PDMS plate is loaded by clamping 
one side to a linear stage motion controller (Newport, Irvine, CA) that is driven by a 
digital manual actuator (Newport, Irvine, CA) (Figure 3.3A-B ), that can be replaced with 
a motorized actuator.  The static condition is loaded by screwing clamps onto a fixed 
overheard bar onto the microscope stage adaptor. 
 
PDMS clamps 









Figure 3.3A-B:  Microscope adaptable mini S.M.A.R.T. 
 (A) Image of completed mini-SMART sitting on the microscope stage with one PDMS 
plate loaded onto straining arm. (B) 3D render of mini SMART AUTOCAD drawing 




top clamp had 3 tapped holes (to screw and secure clamping of PDMS between top and 
bottom clamp).  Additionally, 2 through holes (0.187”) were machined in the top clamps 
to insert alignment pins.  The bottom clamp also had 2 through holes (though slightly 
largely).  Alignment pins served the purpose of fast and precise, loading and unloading.  
In addition, it allowed for precision stacking of the PDMS clamps to 3 levels.   
 
Design of PDMS culture plates and molds  
Elastomeric cultures wells were developed (1) be able to quantify protein secretion levels 
normalized to cell count, (2) to conserve  media use, and (3) to develop a method that 
was more sterile and did not require regular contact with sample culture medium.  The 
elastomeric PDMS plates were generated using Sylgard 184 (Dow Corning, Midland, 
MI) to form three sizes of culture wells surface areas (1cm2, 5cm2, and 35cm2).  Culture 
wells of different sizes were designed in order to satisfy needs for various types in order 
to satisfy needs for various types of analysis (ranging from: image documentation or 
large cell numbers for RNA isolation).  The plate design (SA = 1cm2 ) contained 
alignment markers to ensure consistent clamping from sample to sample. 
 
Mold for PDMS culture plates  
In order to create culture wells, with walls and base constructed of elastomeric PDMS 
material, it was necessary to design a PDMS mold to provide confined structure until the 
viscous unpolymerized PDMS cured into solid elastomeric wells (Figure 3.4B).  The 
mold for 1cm2 surface area well plates included 6 separate Aluminum parts.  The outer 










Figure 3.4:  PDMS clamp unit, mold, and plate. 
(A) 3D angled render of AUTOCAD drawing of PDMS plate-clamp unit. (B) PDMS 






in the center to provide outer shape for 4 wells.  The bottom mold (mirror finished, to 
ensure optical clarity for image documentation) was attached using 4 screws to the outer 
mold to clamp a 0.02” PDMS sheet.  Lastly, 4 inner mold pieces (also mirror finished) 
were inserted and screwed into the outer mold, to provide inner shape for the well walls.  
The placement of the 4 inserts onto the outer mold was designed to provide support with 
venting to allow flow of unpolymerized PDMS to conform to the well shape.  After 
placing all mold components together, the unpolymerized PDMS mixture was made (at a 
1:10 ratio of the Sylgard 184 mix) and pipetted into the crevice between the outer mold 
and 4 inserts. The entire mold was then placed into an oven set at T=60oC and cured for 2 
hrs to allow time for polymerization, where after removal of mold reveals a cured PDMS 
culture plate (Figure 3.4C).  In order to ensure consistent clamping of the PDMS plates, 
through holes were machined into the bottom mold to fit punches that created alignment 
holes in reference to wells for placement of screws when clamping. 
 
Creating PDMS wells with surface a strain gradient 
PDMS wells presenting a surface strain gradient, only under application of tensile strain, 
were created by using O2 plasma to covalently bond a (width = 8mm) strip of 
micromachined glass (t=)1 x (w=8) x (l=7) mm3 to the center bottom surface of a PDMS 
well (Figure 3.5).  
 
Quantification of surface strain of 2D culture  
Internal 2D surface strain in PDMS wells was measured by drawing gridlines onto the 
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Figure 3.5:  Method to create PDMS wells with strain gradient  
Micromachined SiO2 is covalently bound to the bottom surface of a PDMS well using O2 
plasma.  Application of tensile strain reveals a culture surface with regions of low or no 
strain (region directly above micromachined SiO2) in contrast to regions of higher strain 











gridlines in response to applied strain.  The micrometer fixed to the moving plate of the 
mini S.M.A.R.T device distends the well at a precise distance, and the resultant internal 
strain (surface displacement) was digitally measured using IPLAB 4.0, imaging software 
(BD Biosciences, Rockville, MD).  To assess homogeneity of unaltered 2D wells, data 
points were sampled from different locations (n=3) on the culture surface for statistical 
analysis.  For strain gradient measurements, internal strain was assessed at various 
specified locations (n=3) at each applied displacement throughout the PDMS well at each 
strain level. 
 
Quantification of surface strain of 3D fibrin gels  
Internal strain within 3D fibrin gels cultured in PDMS wells was characterized by 
measuring the distance of displacement between microcarrier beads (center to center) in 
response to applied displacement.  A micrometer fixed to the moving plate of the mini 
SMART device was used to displace the material and microscopic image measurements 
were gathered using IPLAB 4.0 imaging software (BD Biosciences, Rockville, MD).  
Cytodex 3 microcarriers (GE Healthcare, Piscataway, NJ) with diameter ~200um were 
uniformly embedded at 600 microcarriers/mL into a fibrin gel, constituted of fibrinogen 
(4 mg/mL; Sigma), aprotinin (500ng/mL; Sigma), and thrombin (25 units/mL).  In order 
to confer uniform strain throughout the gel, a thick PDMS plate (slab of PDMS ~1cm 
thick, with 4 wells created using 1x1cm2 square molds) containing wall reinforcements 




Measuring minimum power requirement 
The minimum power requirement was examined and the force required to distend one 
PDMS well with walls by 110% was calculated to be 1.35N (Figure 3.6).  Force required 
to distend PDMS with no walls was measured as a control, to validate PDMS elastic 
modulus.  In order to determine the design rule required for the linear motor, we assessed 
the forced needed to distend the maximum load (scaled up to 48 PDMS wells) by 110%.  
This calculation yielded the minimum motor power required to be 65N, substantially 
under the 220N load potential of the linear motor used. 
 
Applied strain is conferred and internal 2D strain profile is homogeneous 
The correlation of applied strain to resultant measured internal strain was assessed. 
Stretching 2D PDMS wells using mini SMART and measuring the distance of 
displacement between gridlines demonstrated a linear relationship between applied strain 
and measured internal strain (Figure 3.7).  The strain field was also found to be fairly 
homogeneous within the culture area, as represented by the small variance within each 
data set. 
 
Characterizing surface presentation of a strain gradient (2D) 
To determine whether a surface strain gradient can be achieved by bonding a much stiffer 
(glass) material onto the bottom surface of an elastomeric material (PDMS well) under an 
applied strain of 10% (Figure 3.8A), the displacement of gridlines on the PDMS culture 
surface was measured.  Applying 10% strain resulted in enhanced levels of strain at the 








Figure 3.6:  Force Profile per PDMS well  
Force required to strain one PDMS well by 10% is significantly increased with PDMS 
well walls.  Measurement of force was quantified by incrementally straining substrates at 














Figure 3.7:  Applied strain is directly conferred in 2D. 
Linear correlation between applied strain and measured surface strain within PDMS wells.  
Strain field is relatively homogeneous within PDMS well, as shown by the small error 














Figure 3.8:  Strain gradient within PDMS well for 2D cultures  
(A) A cross sectional profile of a PDMS well with a glass strip covalently bonded to the 
bottom surface of well creates a culture region that is less elastomeric (surface above the 
glass) and regions that experience high internal strain (to the right and left regions of 
glass strip) under application of tensile strain.  (B) Internal 2D strain profile was 
quantified by measuring the displacement between gridlines, drawn throughout the 
culture surface of PDMS well, in response to applied incremental displacements using the 
mini S.M.A.R.T. (n=3).  
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bonded to the bottom side) experienced minimal strain.  This gradient in strain was 
characterized (Figure 3.8B) within the culture surface of one PDMS well. 
 
Internal 3D strain and integrity 
The correlation of applied strain to resultant measured internal strain within 3D fibrin 
gels, contained within PDMS plates was examined. Microcarrier Cytodex beads 
embedded within fibrin gels strained in a linear pattern compared to that of applied strain 
(Figure 3.9A). The integrity of fibrin gels under cyclic tensile loading was measured over 
a duration of 5 days to examine the extent of gel degradation.  Results (Figure 3.9B) 
indicate that only slight levels of in measured fibrin gel degradation occur at day 4 of 
loading. 
 
3.4 Discussion  
The design and construction of S.M.A.R.T. and mini S.M.A.R.T., and the associated 
components demonstrated through characterization studies that these devices can be 
effectively used to systematically examine cellular responses on a micron scale to cyclic 
uniaxial strain.  In particular, these devices will be particularly useful for studies that 
require straining of 2D and 3D constructs an in studying migration or capillary formation 
processes of vascular remodeling. 
 
Measured internal strain was directly correlated with the applied tensile strain in both 2D 
and 3D samples using the custom developed PDMS wells and fibrin gels in PDMS wells, 




Figure 3.9:  Applied strain is conferred, integrity maintained in 3D gels 
 (A) The homogeneity of internal strain in 3D fibrin gels was evaluated by measuring the 
displacement between microcarrier beads (diameter ~200um) that were embedded into 
the fibrin gel using the mini S.M.A.R.T. (B) Integrity of fibrin gel was determined by 
cyclically loading gels and measuring the displacement between beads in response to 
cyclic loading over a 5 day timecourse in comparison to non strained gels (n=3). 
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successfully adaptable to also present a gradient in surface strain.  A novel technique to 
strain 3D gels in custom PDMS chambers with wall supports yielded a uniform strain 
throughout the entire sample.  SMART overcomes the limitations of most designs to 
provide the following features: (1) it can deliver high precision consistent strain (2) all 
strained samples can be image documented (3) various sizes of culture wells are available 
to allow for various forms of analysis (4) various sizes of culture wells are available to 
allow for various forms of analysis.  For future studies, the mini S.M.A.R.T can be used 
for live cells image documentation of cell response to strain and the 3D PDMS plates can 
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MECHANISM OF CYCLIC TENSILE STRAIN REGULATION OF 
ENDOTHELIAL CELL ANGIOGENIC PROCESSES  
 
4.1 Introduction  
Mapping the cues that regulate angiogenesis, the formation of nascent vessels, gives 
insight to the development of therapies for diseases such as peripheral ischemia and 
cancer1. Angiogenesis requires an orchestrated presentation of cues in a specific spatial 
and temporal sequence2.  Much  research in this field has focused on documenting cell 
response to exogenous biochemical cues, and vascular endothelial growth factor (VEGF) 
has been identified as one of the most potent factors during the early stages of 
angiogenesis, activating migration and sprout formation.  Angiopoietin-1 (Ang-1), a 
cytokine that mediates the interactions formed between endothelial cells (ECs) and 
smooth muscle cells (SMCs), and Angiopoietin-2 (Ang-2), an early angiogenic factor that 
inversely acts to disrupt and dissociate these bonds, are both ligands expressed by 
vascular cells that competitively bind to the membrane receptor Tie-2.  Platelet derived 
growth factor-ββ (PDGF-ββ), a chemotactant released by ECs, is a late stage cytokine 
that recruits SMCs to stabilize the nascent EC sprouts.  Understanding the effects of 
soluble factors alone however, is likely insufficient to fully understand the angiogenic 
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process.  Blood vessels are exposed to cyclic tensile strain resulting from blood 
hemodynamic forces, and mechanical signals have been implicated in the modulation of 
EC functions.  Mechanical strain has been reported to alter EC proliferation3, 4, alignment 
5, 6, migration 7, 8 and in vitro sprout formations9,10, likely through activating various 
intracellular signaling pathways11-17.   Altogether, past works suggests that the angiogenic 
process is governed by an interplay between chemical and mechanical signals. 
The effects of cyclic tensile strain on the secretion of angiogenic factors, and the role of 
these factors in strain-mediated alterations in endothelial cell phenotype were analyzed in 
this study.   Human umbilical vein endothelial cells (HUVECs) and human aortic smooth 
muscle cells (HASMCs) 18, were used here as model cell types representing the vascular 
endothelium and supportive elastic layer, respectively.  Vascular cells were cultured in 
2D directly on elastomeric poly(dimethylsiloxane) (PDMS) substrates and in fibrin 3D 
cultures, as an in vitro model for angiogenesis, and both types of culture were exposed to 
cyclic tensile strain at physiologic levels.  Cyclic tensile strain was demonstrated to alter 
EC phenotype and Ang-2 expression, and the alterations in Ang-2 mediated changes in 
EC migration, and in vitro capillary formation. 
 
4.2 Materials and Methods 
Cell Culture 
Human umbilical vein endothelial cells (HUVECs, Cambrex, Walkersville, MD) and 
human aortic smooth muscle cells (HASMCs, Cambrex, Walkersville, MD), were 
cultured at 37oC, 5% CO2 in endothelial growth medium (EGM-2) and smooth muscle 
cell growth medium (SmGm-2), respectively (Cambrex, Walkersville, MD), containing 
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2% FBS.  HUVECs were used between passages 3 and 6 and HASMCs were used 
between passages 3 and 7. 
 
Quantification of migration in response to chemotactic gradients  
HUVECS were seeded (1x104 cells/well) in basal media (EBM-2) into the upper 
reservoir of a transwell chemotaxis insert (Corning Life Sciences) and exposed to a range 
of specific growth factors concentrations presented in the lower reservoir.  The bottom 
surface of the transwell inserts were coated with 2ug/mL of fibronectin (Sigma) for 24 hr 
and rinsed in PBS prior to use.  Cells were allowed to migrate across a (3 µm pore) 
polycarbonate porous membrane for 12 hr in a humidified incubator with 5% CO2 at 
37oC.  After 12 hrs, all cells that did not migrate were removed by PBS rinsing and gentle 
cotton swabbing.  Migrated cells on the bottom surface of the filter were subsequently 
fixed in 3.7% formaldehyde (Electron Microscopy Sciences, Hatfield, PA) for 15 minute.  
The membrane was then rinsed in PBS and stained using DAPI (300nM) (Molecular 
Probes, Eugene, OR) for 15 min, cut and placed onto a microscope slide for fluorescent 
microscope imaging (Olympus IX81).  Cells in five random fields (at 100x 
magnification) were counted to quantify average number of migrated cells per insert. 
Data represent means of the number of migrating cells per condition normalized to the 
negative control (no growth factor). 
 
Quantification of migration in response to cyclic strain 
Custom polydimethylsiloxane (PDMS) elastomeric wells were prepared for cell culture 
by activating their surface through ultraviolet irradiation for 10 min, followed by coating 
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the surface with fibronectin (2ug/mL) for 2 hrs40 to enhance cell adhesion. Cells were 
seeded in 2 mm diameter circular activated regions created by placing a non-coated 
silicon sheet, containing a 2 mm diameter hole, onto the bottom sheet prior to cell 
seeding, and seeding cells into the resultant well formed by the top sheet10.  HUVECs 
were statically cultured in the 2mm diameter region for 24 hrs and subsequently, the 
PDMS mask was removed, and samples were loaded onto strain device and cells were 
allowed to migrate from the confluent circular 2 mm diameter population under cyclic 
strain loading for a duration of 2 days. All PDMS plates were strained using a custom 
built linear motor that was computer controlled.  Cells were all strained at a frequency of 
1Hz and at strain amplitude of 7%.  Distance of cell migration in response to strain was 
normalized to cells experiencing no application of strain. 
 
In vitro angiogenesis: sprouting assay  
HUVECs were dynamically seeded, using spinner flasks, onto cytodex-3 microcarriers 
(GE Healthcare, Piscataway, NJ) over a 24 hr incubation at 37oC (Figure 4.1).  The cell 
coated microcarriers were then maintained under agitated culture to prevent aggregation 
between microcarriers or attachment to culture flask.  Cell coated microcarriers were 
embedded at 600 microcarriers/mL into a fibrin gel, constituted of fibrinogen (4 mg/mL; 
Sigma), aprotinin (500ng/mL; Sigma), and thrombin (25 units/mL).  A range of 
exogenous recombinant human growth factors: vascular endothelial growth factor 
(rhVEGF, R&D systems, Minneapolis, MN) at 1-50 ng/mL, angiopoietin-2 (rhAng-2, 
R&D systems, Minneapolis, MN) at 1-200 ng/mL, angiopoietin-1 (rhAng-1, R&D 






Figure 4.1:  Method to in vitro angiogenesis: sprouting assay. 
Microcarriers and ECs were dynamically cultured in a spinner flask overnight to allow 
adhesion of ECs onto the microcarriers.  Microcarriers seeded with ECs were then 
embedded into a fibrin gel and stimulated with external factors (cytokines or cyclic 







1-50 ng/mL and hepatocyte growth factor (rhHGF, Chemicon) at 20ng/mL were added to 
the culture media, and medium was exchanged every 24 hours.  All static sprouting 
assays were assayed after 5 days and all cyclically strained samples, after 48 hours.  
Following the culture period, samples were immediately fixed in 4% paraformaldehyde 
(EMS, Hatfield, PA).  Data shown represents the average number of sprouts, where the 
total sprouts per a well were normalized to the total beads per well.  High resolution 
images (100x) of sprouts were captured using an inverted fluorescent microscope 
(Olympus IX81).  A sprout is defined as a structure protruding from a microcarrier that is 
composed of more than one cell (Figure 4.2). 
 
Quantification of angiogenic protein secretion  
HUVECs were seeded into treated PDMS elastomeric wells at confluence (4x105 
cells/cm2), and statically cultured for 24 hrs at 37oC prior to loading onto the mechanical 
tensile strain device.  Cytokine secretion by HUVECs and HASMCs into the culture 
medium was analyzed by collecting the medium and employing commercial, quantitative 
sandwich enzyme immunoassay techniques (R&D Systems, Minneapolis, MN). 
 
Real-time RT-PCR  
Extraction of total HUVEC RNA was performed using RNeasy Mini Kit (Qiagen, 
Valencia, CA).  cDNA was generated from 200ng of total RNA using Thermoscript 
cDNA synthesis kit (Invitrogen) according to manufacturer specifications.  Amplification 
of target cDNA sequences using gene specific primers (hAng-2, Qiagen) was performed 








Figure 4.2:  Sprout formations by HUVECs. 
HUVECs seeded on microcarriers embedded into fibrin gels were stimulated (either by 
varying cytokine concentration, conditioned media, or cyclic strain) to form in vitro 
sprouts.  Image documentation of sprouts were observed after 5 days of external 
stimulation through use of (A) confocal microscopy, immunostaining for CD31 




SYBR-greenMM (Qiagen), 5uL DEPC water, 5uL sample cDNA, and 2.5uL of primer 
(Qiagen).  Settings for PCR reaction were as follows:  denaturing phase = 95oC for 15 sec, 
annealing phase = 50oC for 15 sec, and elongation phase = 72oC for 15 sec (39 cycles).  
Each cDNA test sample was assayed in technical duplicates, from triplicate biological 
samples.   Expression results were normalized to that of glyceraldehydephosphate 
dehydrogenase (GAPDH). 
 
Vector construction and synthesis 
The short hairpin RNA (shRNA) sequence was designed and cloned into pSilencer 2.1-
neo vector (Ambion).  Briefly, the shRNA 63mer oligonucleotide (IDTDNA) containing 
the sense strand, loop, antisense strand, and pol III terminator were annealed, and inserted 
via ligating into flanked BamHI and Hind III sites, following a U6 human promoter. 
Plasmids were transformed into E.coli-DH5α competent cells (Invitrogen) as per 
manufacturer instructions.  DNA sequencing (using ABI3730xl Genetic Analyzers) was 
performed to confirm propagation and purification of product using Plasmid Maxi Kit 
(Qiagen). Oligonucleotide for shRNA (Ang-2) used was as follows 5’-
GATCCGCAACGCTATGTGCTTAAATTCAAGAGATTTAAGCAC 
ATAGCGTTGCTTTTTTGGAAA-3’.  A scrambled shRNA sequence containing a 
random oligonucleotide sequence that was BLAST41 against the human genome was 
simultaneously transfected in all experiments as a negative control. 
 
Plasmid transfection and FACS 
HUVECs were cultured to 90% confluence, trypsinized and centrifuged to pellet.  Cells 
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 (2x106 cells/100uL), shRNA plasmid, and pmaxGFP were then resuspended in a 
transfection medium (AMAXA, Cologne, Germany) and electroporated using the Amaxa 
nucleofector device.  After exposure, cells were cultured in EGM-2 with a basal level 
(10ug/mL) of geneticin for selective pressure.  Positive cells were selected using FACS 
(BD Biosciences LSRII flow cytometer) and subsequently used for experiments.  To 
validate effective inhibition of Ang-2, FACS sorted cells were cultured in 96 well plates 
(2x104 cells/well) in EGM-2 with 10ug/mL geneticin and protein secretion levels were 
measure daily over a time-course of 5 days using a quantitative sandwich enzyme 
immunoassay technique for Ang-2 (R&D Systems, Minneapolis, MN).   
 
Statistical Analysis 
Statistical comparison of two samples was performed using a two-tailed Student t-test 
when applicable.  P < 0.05 was considered as statistically significant. 
 
4.3 Results 
Cyclic tensile strain alters endothelial phenotype and angiogenic factor secretion 
The effects of cyclic strain on EC migration and in vitro sprout formation were first 
confirmed.  Cyclic tensile strain (7%, 1 Hz) enhanced, by 1.6 fold, the directional 
migration of HUVECs in 2D culture (Figure 4.3A), as expected19.  Two days of cyclic 
tensile strain also enhanced sprout formation by HUVECs in fibrin gels by 4 fold, 
compared to static culture (Figure 1B), again in agreement with earlier investigations9.  
Addition of recombinant human VEGF-165, a known stimulant to capillary formation20, 
21, also increased sprout formation both under static and strained conditions (Figure 4.3B),  
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Figure 4.3A-B: Cyclic strain enhanced EC migration and sprout formation 
Cyclic tensile strain at a frequency of 1Hz and ε = 7% for a duration of 2 days enhanced 
directed EC migration and sprout formation. (A) Directed migration of HUVECs on 
PDMS with no strain and application of strain was quantified by measuring the distance 
on the culture surface to which the edge of the cell population migrated in the direction 
normal to strain direction, normalized to the extent of cell migration parallel to strain 
application. (B) Formation of sprouts by endothelial cells in 3D culture, as a function of 
static culture (no strain) or application of cyclic strain.  Sprouting was analyzed in the 
absence (control) or presence (VEGF) of exogenous VEGF in the medium. Values 







confirming the expected biological responsiveness of the cells used in these studies.  
 
To examine whether cyclic strain upregulated genes involved in angiogenesis, the levels 
of angiogenic proteins secreted by vascular cells were quantified over a 5 day time-
course of cyclic strain. Cyclic strain of HUVECs led to a 5-fold upregulation in the 
secretion of PDGF-ββ (Figure 4.4A), and a 4.8-fold upregulation of Ang-2 (Figure 4.4B).  
In contrast, cyclic strain of HASMCs resulted only in a slight enhancement of Ang-1 
(Figure 4.4C), while secretion of VEGF did not appear to be effected by strain (Figure 
4.4D).  In both strained and non-strained conditions, the secretion of PDGF-ββ and Ang-
2 by HASMC, and Ang-1 and VEGF by HUVECS, respectively, was minimal.  The time 
course of upregulation of PDGF-ββ and Ang-2 secretion by HUVECs was next 
investigated.  Ang-2 expression was increased 3-fold by day 1 and then slowly subsided 
over the ongoing 13 days to control levels (Figure 4.4E).  PDGF secretion, in contrast, 
did not rise until 2 days of cyclic stretch, and then quickly returned to baseline control 
levels (Figure 4.4F).  As minimal effects of cyclic strain on angiogenic factor secretion 
by HASMC were noted, all subsequent studies focused on HUVECs. 
 
Role of Ang-2 in endothelial cell migration and sprout formation  
To determine if the levels of altered angiogenic factors resulting from cyclic strain were 
capable of altering EC phenotype, HUVECs in fibrin gels were exposed to exogenous 
recombinant human Ang-2, Ang-1, PDGF and VEGF, at levels corresponding to those 
produced by cells under strained conditions.  Ang-2 and VEGF enhanced the formation 
of sprouts (Figure 4.5A-B), while PDGF (Figure 4.5C) and Ang-1 (Figure 4.5D) had no  
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Figure 4.4A-F:  Cyclic strain regulates temporal secretion of angiogenic factors  
Cyclic tensile strain upregulated secretion of angiogenic factors by vascular cells, in a 
temporal manner.  (A-D) Secretion of PDGF, Ang-2, Ang-1 and VEGF by HUVECs and 
HASMCs was quantified after exposure to 5 days of cyclic strain.  Protein levels were 
quantified using enzyme immunoassays and values (n=3) were normalized to total cell 
number per well. (E) Expression profiles of HUVECs secretion of Ang-2 and PDGF in 
response to 14 days of cyclic strain.  Values represent normalized protein levels (n=3) 
under strain to protein levels secreted under static (no strain) conditions. * indicative of P 
< 0.05 and ** indicative of P < 0.005.  
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discernible effects.  The effects of these factors on HUVEC migration across porous 
transwell membranes was next examined, and VEGF was found to enhance HUVEC 
migration (Figure 4.5E), concurring with known effects of this cytokine22.  Ang-2 
similarly enhanced HUVEC migration, while Ang-1 had no effect (Figure 4.5E). 
To test whether cyclic strain-induced upregulation of Ang-2 was causative for the strain 
induced increase in EC migration and sprouting, RNAi was used to knockdown the 
endogenous expression of Ang-2 in HUVECs.  HUVECs were transfected with a plasmid 
that was designed and constructed to release a 63mer silencing hairpin ribonucleic acid 
(shRNA) that binds specifically to the intracellular mRNA of Ang-2 and blocks the 
translation of this protein.  Examination of Ang-2 secretion by cells positively transfected 
with shRNA (Ang-2) confirmed a dramatic inhibition of Ang-2 expression for 4 days 
following treatment (Figure 4.6A).  The baseline (no cyclic strain) migration of ECs with 
shRNA (Ang-2), was decreased by approximately by 1.6 fold (Figure 4.6B), while cells 
subjected to strain exhibited a 2-fold decrease in migration with shRNA treatment (Figure 
4.6C).  Inhibiting Ang-2 also resulted in a 2.2 fold decrease in sprouting with exposure to 
cyclic strain, in both the absence and presence of exogenous VEGF in the culture 
medium (Figure 4.6D). Finally, gene expression levels of Ang-2 and its receptor (Tie-2) 
in HUVECs were analyzed using real time RT-PCR, and cyclic strain for 5 days resulted 
in 1.5-fold and 2-fold increases in mRNA levels for Ang-2 and Tie-2, respectively 
(Figure 4.6E). 
 
4.4 Discussion  
The results of these studies indicate that Ang-2 can activate ECs to migrate and form  
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Figure 4.5A-E:  Ang-2 and VEGF enhance HUVEC migration and sprout formation 
Exogenous application of Ang-2 and VEGF enhanced sprout formation and migration of 
HUVECs. Sprout formation in response to recombinant (A) Ang-2, (B) VEGF, (C) 
PDGF, and (D) Ang-1 was quantified (n=4).  (E) 2D migration of HUVECs across 
transwell inserts after 12 hrs in static culture with exposure increasing concentrations of 
various cytokines (n=4).  * indicative of P < 0.05. 
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Figure 4.6A-E:  Knockdown of Ang-2 decrease EC responsiveness to strain  
RNAi was utilized to determine the role of Ang-2 in HUVEC response to cyclic strain. 
(A) Effectiveness of shRNA knockdown of endogenous Ang-2 secretion by HUVECs 
transfected with shRNA to Ang-2 (Ang-2), a control shRNA (scrambled sequence), and 
control untreated cells was quantified using enzyme immunoassays, daily (n=5) over 4 
days. Values represent mass of protein secreted, normalized to total cell phenotype of 
endothelial cells, characterized here by directed cell migration and in vitro  
number per well (B) Level of static HUVEC migration, over 24 hrs, across transwell 
inserts, normalized to untreated control cells, with either shRNA to Ang-2 (Ang-2) or 
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scrambled shRNA control (scrambled) (n=4) (C) Level of HUVEC migration in response 
to 48hrs cyclic strain on PDMS.  Values represent number of cells under cyclic strain that 
migrated out of original confined circular region, d=2mm, normalized to static, non-
strained conditions (n=3). (D) Formation of sprouts under application of strain was 
quantified using HUVECs with and without Ang-2 shRNA treatment, in culture medium 
with or without added VEGF. Values (n=3) are normalized to a non-strained, no growth 
factors control.  (E) Cyclic strain effect on gene expression of Ang-2 and Tie-2 mRNA 
levels was quantified by real time RT –PCR, normalizing all values (n=6) to GAPDH 
















sprouts, processes important to the early stages of angiogenesis. The angiogenic 
sprout formation was also enhanced in response to cyclic uniaxial strain. Cyclic strain 
increased expression of both Ang-2 and its receptor, Tie-2, in ECs, and this increased 
Ang-2 expression mediated the cyclic strain induced alterations in EC angiogenic 
phenotype.  
 
Cyclic strain upregulated EC secretion of angiogenic cytokines, specifically, PDGF-ββ 
and Ang-2.  Previous studies reported that cyclic strain enhanced the expression of 
PDGF-R8, 23, and shear stress enhanced gene expression of PDGF-ββ24, 25 and Tie-226.  
However, upregulation of PDGF-ββ and Ang-2 in response to cyclic strain has, to our 
knowledge, not been previously documented.  Interestingly, VEGF, a potent factor in 
angiogenic activation was not affected by strain, although regulation of this cytokine is 
governed by other local cues27.   The temporal profile of increased angiogenic cytokine 
secretion by ECs in response to cyclic strain was striking, as Ang-2, a factor important to 
the initiation of angiogenesis2 was upregulated early, followed by later expression of 
PDGF, which plays important roles in later stages of angiogenesis2, 28.This data suggests 
that cyclic strain modulates angiogenesis by altering the balance of angiogenic factors, 
and by temporally mediating the upregulation of factors driving activation versus those 
promoting vessel stabilization.  
 
Ang-2 was found in this study, even in the absence of mechanical stimulation, to enhance 
sprout formation and migration of endothelial cells. The role of angiopoietins in vascular 
development has been the subject of active investigation, and until recently it was 
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believed that Ang-1 played solely a stabilizing role via activation of the tyrosine kinase 
receptor Tie-229 while Ang-2, the antagonist to Ang-1, was believed to play more of a 
facilitative role30.  For example, expression of Ang-2 was identified primarily at sites of 
active vessel remodeling30-33.  However, recent studies demonstrate that there may exist a 
contextual role to Ang-2’s functions, as it serves in some instances to inhibit vascular 
leakage34 while in other situations it may function as a proinflammatory cytokine35.  
Increased secretion of Ang-2 in response to biochemical stimulants has also been 
documented, supporting the suggestion36 that Ang-2 function is more complex  than 
initially identified37.  Although VEGF-A and angiopoietins play distinct roles in vascular 
development, they also have complementary and coordinated roles. VEGF-A, has been 
shown to modulate migration22 and in vitro capillary formation38 of ECs and Ang-2, at 
levels secreted in response to cyclic strain signals, appears to have similar effects on ECs. 
While the molecular mechanisms linking cyclic strain to Ang-2 expression are not clear, 
they likely involve the various intracellular signaling pathways previously documented to 
mediate mechanical effects on ECs12, 39 that induce local differentiation and the formation 
of nascent blood vessels.   
 
The findings of this study provide a specific example of how localized mechanical 
signals can be translated into biochemical cues capable of signaling over physiologic 
relevant distances via chemical gradients.  While not addressed in this report, this 
coupled mechanism may provide new points to intervene and regulate the angiogenic 
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ROLE OF CYCLIC STRAIN IN MODULATING RECRUITMENT OF  
SMOOTH MUSCLE CELLS TOWARDS MIGRATING ENDOTHELIAL CELLS  
 
5.1 Introduction  
The recruitment of smooth muscle cells (SMCs), critical to blood vessel function and 
maturation1-3, comprises the medial layer that stabilizes neovessels formed from 
endothelial cells (ECs) during angiogenesis.  Understanding the cues that regulate SMC 
migration gives insight to vascular diseases4 associated with abnormal states, as in 
atherosclerosis5 and cancer6, 7.  A number of proximal environmental cues that control 
SM migration have been investigated, and platelet-derived growth factor (PDGF-BB), 
has been identified as the most potent chemoattractant for cultured vascular SMCs8-12.  
Other soluble factors secreted by ECs, with lesser chemotactic effect on SM migration, 
include basic fibroblast growth factor (bFGF)13 and heparin-binding epidermal growth 
factor (HB-EGF)14.   Physiologically relevant hemodynamic forces have also 
demonstrated to modulate SM migration15-17, phenotype18-21, and intracellular signaling 
molecules22-24.  In vitro techniques used to assess SM migration traditionally employ the 
use of the Boyden chamber, or a similar type of device, to measure cell migration across 
porous membranes25.  Alternative methods using radiolabeled SMCs infiltration into 
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amniotic membrane in response to have been quantitatively analyzed in response to 
chemotactic cues26.  Novel methods utilizing nanoparticles bound to SMC surface 
epitopes27, have been used to quantify proliferation and can likely be adapted to studying 
migration of SMCs.  
 
The effect of cyclic tensile strain on EC secretion of paracrine factors, and the role of 
these factors in mediating SMC migration were analyzed in this study.   Isolated colonies 
of human umbilical vein endothelial cells (HUVECs) and human aortic smooth muscle 
cells (HASMCs) were seeded in co-culture and at physiologically relevant distances as an 
in vitro model for neovessel development, specifically to assess strain regulated 
chemotactic effects of PDGF.  An elastomeric homogeneous PDMS culture well that 
presented regions of high and low surface strain (Chapter 3) was used in combination 
with a precise seeding method to pattern (each colony = 1mm in diameter) and expose 
ECs and SMCs to individual levels of cyclic tensile strain.  The magnitude of cyclic 
tensile strain was shown to enhance the number, but not directionality of migrating SMCs.  
In the co-culture system, PDGF secreted by strain-mediated migrating ECs demonstrated 
to provide the directional cues for SMCs recruitment towards these EC colonies. 
 
5.2 Materials and Methods  
Vascular Cell Culture   
Human umbilical vein endothelial cells (HUVECs, Cambrex, Walkersville, MD) and 
human aortic smooth muscle cells (HASMCs, Cambrex, Walkersville, MD), were 
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cultured in a humidified incubator at 37oC, 5% CO2, in endothelial growth medium 
(EGM-2) and smooth muscle cell growth medium (SmGm-2), respectively (Cambrex, 
Walkersville, MD), containing 2% FBS.  HUVECs were used between passages 3 and 6 
and HASMCs were used between passages 3 and 7.  Co-cultures of HUVECs and 
HASMCs were maintained in culture medium that constituted of 1:1, EGM-2 and 
SmGm-2. 
 
Creating an array of isolated cell cultures (each colony diameter = 1mm) 
Custom polydimethylsiloxane (PDMS) elastomeric wells were prepared for cell culture 
by activating their surface through ultraviolet irradiation for 10 min, followed by coating 
the surface with fibronectin (2ug/mL) for 2 hrs28, 29 to enhance cell adhesion.  
Cell colonies grown in 1 mm diameter regions were patterned (Figure 5.1) to form a 
rectangular array of (4 x 3) colonies on a PDMS substrate with strain gradients (Figure 
5.2).  This modified masking technique utilizes a coated silicon sheet, containing an array 
of 1 mm diameter holes and was placed directly onto the bottom sheet prior to cell 
seeding.  Individually, HUVECs and HASMCs were suspended into a fibrin solution 
constituted of fibrinogen (4 mg/mL; Sigma) and thrombin (25 units/mL) and were 
precisely seeded (250 cells/well) into the resultant (1mm diameter) wells formed by the 
top sheet.  After fibrin gelation, cells were statically cultured in the 1mm diameter 
regions in designated medium with Plasmin (10ug/mL) for 24 hrs.  Subsequently, the 
PDMS mask was removed, and samples were loaded onto the strain device and cells were 
allowed to migrate from the confluent circular 1 mm diameter population under cyclic 
strain loading for a duration of 2 days.  
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Quantification of Vascular Cell Migration: Number, Rate, and Directionality in 
response to cyclic tensile strain 
All PDMS wells were strained using a custom built linear motor that was computer 
controlled.  Cells were strained at a frequency of 1Hz and at strain amplitude of 7%.  To 
detect and document coculture migration in response to strain, vascular cells were fixed 
in 3.7% formaldehyde (Electron Microscopy Sciences, Hatfield, PA) for 15 minutes and 
rinsed in PBS.  Expression of CD31, an endothelial-specific membrane marker, was 
detected using a mouse antibody against human CD31 (1:20 dilution; Dako Cytomation) 
followed by a secondary Rhodamine conjugated goat-anti-mouse IgG antibody (1:50 
dilution, Jackson ImmunoResearch, West Grove, PA).  A nuclear stain DAPI (300nM) 
(Molecular Probes, Eugene, OR), was also applied onto the samples for 15 min to detect 
the location of all cells.  The base of the PDMS wells were then cut and placed onto a 
microscope slide for fluorescent microscope imaging (Olympus IX81) for quantification. 
Refer to Appendix B for scripts to run automated large mosaic image capture.  Fraction 
of cell migration and proliferation in response to strain was normalized to cells 
experiencing no application of strain.  The average velocity was quantified by measuring 
the change in distance of the cell colony periphery (y-axis) from the original 1mm 
diameter culture, over 48hrs.  SMC migration in response to a PDGF source or an EC 
source was quantified by measuring the fraction of cells that migrated outside of the 
original 1mm-diameter circular region.  Directionality of SMC migration was assessed by 
first quantifying the number of cells that migrated outside of the original 1mm-diameter 
circular region, then by measuring the fraction that preferentially migrated either to the 
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Figure 5.1:  Method to culture a precise array of ECs and SMCs  
Culturing isolated colonies of human vascular cells in PDMS wells enabled quantitative 
analysis of cell migration in response to cyclic tensile strain.  PDMS wells that present a 
gradient in surface strain, when under application of strain, were overlaid with a PDMS 
mask with holes used to confine cell culture into discrete colonies.  Cells in fibrin gel 
solution were seeded into each hole and culture medium with Plasmin was added to 
slowly degrade the gel and to form a monolayer culture.  Mask was removed to reveal an 
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Figure 5.2 A-D:  Array of vascular cell colonies in PDMS well with strain gradient 
Patterned array of vascular cell colonies on PDMS culture well that presents a gradient in 
surface strain (A) Dimension and coordinates of cell colony array on PDMS well (B) 
Direction of strain application (ε=10%) with respect to cell array coordinate (C) PDMS 
well strain profile (D) A combined view illustrating which cell colonies, at defined 
regions, are exposed to different levels of tensile strain. 
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Mathematical model to define PDGF concentration profile 
The secretion of PDGF by HUVECs in response to cyclic strain is assumed as a 
continuous production from an EC colony point source.  The equation below enables 
determination of diffusion length and concentration profile.  The culture well system is 
assumed a semiinfinite medium, with negligible consumption of PDGF by SMCs due to 
continuous production and constant diffusion.  The diffusion profile describes a solute at 













The concentration (C) of PDGF, at a radial distance r from the point source as a function 
of time (t), where M is the mass of the PDGF source, and D is the diffusion coefficient 
(1x10-6 cm2/s).  Values for M were determined experimentally (0.0514 pmol/ HUVEC 
colony).  This model predicts the maximum distance r  that is required in order to ensure 
paracrine sensing proximity of PDGF from HUVECs, by HASMCs. 
 
Quantification of HASMC Migration in Response to Chemotactic Gradients  
HASMCs were seeded (1x104 cells/well) in basal media (SMBM-2) into the upper 
reservoir of a transwell chemotaxis insert (Corning Life Sciences, Wilkes-Barre, PA) and 
exposed to (1) a range of PDGF concentrations (1-100 ng/mL) (R & D Sytems, 
Minneapolis, MN) and (2) to conditioned media from HUVECs from both cyclically 
strained samples or static cultures (with media exchanged every 24 hrs, taken from day 5).    
The bottom surfaces of the transwell inserts were coated with 2ug/mL of fibronectin 
(Sigma-Aldrich) for 24 hrs and rinsed in PBS prior to use.  Cells were allowed to migrate 
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across a (3 µm pore) polycarbonate porous membrane for 24 hr in a humidified incubator 
with 5% CO2 at 37oC.  After 24 hrs, all cells that did not migrate remaining the top insert 
were removed by PBS rinsing and gentle cotton swabbing.  Migrated cells on the bottom 
surface of the filter were subsequently fixed in 3.7% formaldehyde (Electron Microscopy 
Sciences, Hatfield, PA) for 15 minutes.  The membrane was then rinsed in PBS and 
stained using DAPI (300nM) (Molecular Probes, Eugene, OR) for 15 min, cut and placed 
onto a microscope slide for fluorescent microscope imaging (Olympus IX81).  
Neutralizing effects of SM membrane bound PDGF-receptor (PDGF-R) on SMC 
migration were assessed by pre-incubating HASMCs for 30 minutes in 100 ug/mL anti-
PDGFR (R & D Systems, Minneapolis, MN).  Cells in five random fields (at 100x 
magnification) were counted to quantify average number of migrated cells per insert. 
Data represent means of the number of migrating cells per condition normalized to the 
negative control (no growth factor). 
 
Immuncytochemistry of PDGF-R 
Immunofluorescent visualization of PDGF-R expression on the membrane of HASMCs 
was performed using standard methods.  HASMCs were cultured for 24 hrs on Lab-Tek 
chambers and activated PDMS substrates, both surfaces coated with 2ug/mL Fibronectin 
(Sigma).  HASMCs were cultured for an additional 48hrs, those in Lab-Teks exposed to a 
range of rhPDGF concentrations (1-100ng/mL) and those in PDMS wells both under 
static culture and strain application.   Subsequent to removal from culture, cells were 
fixed in 3.7% formaldehyde (Electron Microscopy Sciences, Hatfield, PA) for 15 minutes, 
rinsed in PBS, and expression of PDGF-R was detected using a goat polyclonal antibody 
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against the human PDGF-Rβ (10 ug/mL; R&D Systems) followed by a secondary 
Alexfluor488 conjugated rabbit-anti-goat antibody (2ug/mL; Invitrogen).  A fluorescent 
microscope (Olympus IX81) was used for image documentation.  Quantification of 
PDGF-R expression was assessed by measuring the average relative fluorescence units 
(RFU) of images taken with a 10x objective (IPLAB 4.0). 
 
5.3 Results 
Strain magnitude alters vascular cell proliferation, average velocity and direction  
The response of vascular cell migration to varying magnitudes of cyclic tensile strain was 
assessed by the fraction of cells that migrated out from original cell culture region, the 
average velocity outside of the original cell culture region, and the directionality of the 
cell colony, all at a frequency of 1Hz.  Cyclic tensile strain enhanced the fraction of 
migrating HUVECs by 2-fold when an amplitude of 6% cyclic strain was applied, while 
at an amplitude of 13% cyclic strain,  the fraction of cells migrating was enhanced nearly 
4-fold (Figure 5.3A).  The average velocity of HUVEC migration at 13% cyclic strain 
was 15-fold (Figure 5.3B) as compared to that at static conditions, amounting to an 
averaged velocity of  <v>=15um/hr.  Migration of HUVEC colonies exhibited a clear 
directionality, perpendicular to the line of strain application (Figure 5.3C).  Two days of 
cyclic tensile strain similarly enhanced the fraction of migrating HASMCs nearly 3-fold 
at 13% strain as compared to non strained conditions, but only negligibly at 6% (Figure 
5.4A).  The average veloicty of HASMC migration, at 13% strain  
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Figure 5.3 A-C:  Response of EC migration to increasing strain magnitudes 
HUVEC migration, velocity, and directionality are enhanced in response to increasing 
cyclic tensile strain magnitude. Migration of HUVEC was quantified after subject to 2 
days of cyclic strain at varying magnitudes of strain: 0 (no strain), 6, and 13%. (A) 
Distance of migration out of the original seeding area and (B) velocity of migration, as 
taken from the maximum distance in the y-direction of cell colony perimeter over a 48 hr 
duration and (C) Fluorescent mosaic image combines over 30 images taken at (100x) 
with nucleus immunostained with (DAPI/blue) to show directionality of migrating ECs 
(n=3). 
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Figure 5.4 A-C:  Response of SMC migration to increasing strain magnitudes 
HASMC migration, velocity are enhanced in response to increasing cyclic tensile strain 
magnitude, with no clear directional migration. Migration of HASMC was quantified 
after 2 days of cyclic strain at varying magnitudes of strain: 0 (no strain), 6, and 13%.  
(A) Distance of migration out of the original seeding area and (B) velocity of migration, 
as taken from the maximum distance in the y-direction of cell colony perimeter over a 48 
hr duration and (C) Fluorescent mosaic image combines over 24 images taken at (100x) 






was approximately 6-fold as compared to non strained conditions, notably slower than 
HUVEC migration rates (Figure 5.4B).  Additionally, HASMCs over the 2 day strain 
duration did not demonstrate directional migration (Figure 5.4C). 
 
SM migration enhanced by PDGF and EC conditioned media  
To determine whether HASMCs were chemotactically responsive to PDGF (both 
recombinant human PDGF and endogenous PDGF secreted by HUVECs), HASMC 
migration was first assessed across porous transwell membranes.  HASMCs migration 
increased when exposed to larger dosages of exogenous recombinant human PDGF 
(Figure 5.5A).   
 
More physiologically relevant, conditioned media taken from strained ECs (demonstrated 
an upregulated secretion of PDGF, Chapter 3) demonstrated to enhance migration by 
nearly 2-fold, as compared to conditioned media taken from cells in non strained cultures.  
To determine whether the enhanced SM migration was a direct result of the strain-
mediated increased PDGF levels, we neutralized PDGF-receptor (PDGF-R) on HASMCs 
and reassessed their response to conditioned media taken from strained ECs.  
Interestingly, neutralizing HASMC responsiveness to PDGF (by neutralizing the PDGF-
receptors) decreased migration by 45% (Figure 5.5B).    
 
Next the migration of HASMCs migration on PDMS substrates was evaluated in 
response to (1) a depot of rhPDGF and (2) a depot of CM from strained.  To first 
determine the validity of the distance of chemotactant from the HASMC colony, a  
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Figure 5.5 A-D: Model of PDGF concentration profile and SM migration to PDGF 
 PDGF enhances HASMC migration and recruits via chemotactic gradients (A) 
Exogenous application of rhPDGF enhance SM migration across transwells inserts after 
24 hrs in static culture with exposure increasing concentrations. (B) Application of 
endogenous PDGF secreted from strained HUVECs enhanced HASMC with and without 
PDGF-R neutralized, migration across transwell inserts. (C)  Mathematical model 
representing the PDGF concentration profile from HUVEC point source.  (D) SM 
migration was enhanced towards depo source: rhPDGF and CM from strained ECs over 




mathematical model was used to approximate the diffusion length of PDGF (taken as a 
continuously generating point source).  The concentration profile validates a diffusion 
length of 2 mm, from the originating PDGF source, therefore demonstrating that a 
chemotactic gradient exists (Figure 5.5C).  The migration of HASMCs towards a depot of 
rhPDGF and a depot of CM from cyclic strained HUVECs demonstrated a respective 2-
fold 2.25-fold enhancement in migration (Figure 5.5D) as compared a blank depot with 
no stimulants.   
 
Bioactivity of PDGF-R on SMCs enhanced by PDGF and cyclic strain  
To determine if HASMC bioactivity of PDGF-R was regulated by strain, HASM cultures 
were cyclically strained over a duration of 2 days and qualitatively assessed via 
immunostaining of the PDGF-R.  Visual comparison clearly demonstrated that cyclic 
strain of HASMCs distinctly enhanced PDGF-R detection as compared to non strained 
conditions (Figure 5.6A).  Next, SM PDGF-R bioactivity was examined in response to 
chemical stimulation of increasing rhPDGF levels.  The relative fluorescent units (RFU) 
quantitatively showed that HASMC PDGF-R bioactivity increased with application of 
increasing rhPDGF (Figure 5.6B).   
 
Directing SMC recruitment towards migrating ECs by cyclic strain 
Strain activated, migrating HUVECs, and its secreted PDGF paracrine effects on 
HASMC migration, was assessed using 2D co-culture system (Figure 5.7A).  Results 
demonstrated a 2-fold increase in SM migration (when coculture with non strained  
HUVECs), while when SMCs were co-cultured with strained HUVECs, the migration of  
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Figure 5.6 A-B:  Bioactivity of SM PDGF-R enhanced by cyclic strain and rhPDGF  
(A) Expression of PDGF-R was enhanced after 48 hrs of cyclic strain application to 
HASMCs and documented using fluorescent microscopy, with PDGF-R immunostained 
(Green). (B) Relative fluorescence Units (RFU) of immunostained PDGF-R was 
quantified in response to SMCs exposed to increasing rhPDGF concentrations over a 3 
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Figure 5.7 A-D: Cyclic strain mediates EC paracrine signaling on SMC recruitment 
HASMC migration via intercellular communication between HUVECs and HASMCs is 
enhanced in response to cyclic tensile strain.  (A) Location of co-cultured cell colonies on 
PDMS well. (B) HASMC migration from original seeding location is enhance when in 
co-culture with HUVECs, and particularly, under cyclic strain over 48 hrs.  (C) Mosaic of 
30+ images (at 100x) illustrating migration of HASMCs towards HUVECs.  (D) 
Directionality of HASMC migration from original seeding location is polarized toward 






HASMCs were enhanced by 5-fold (Figure 5.7B), as compared to a negative control 
(SMCs with no co-culture, no strain).  There was no notable directionality of HASMC 
migration when co-culture with non-strained HUVEC colonies.  However, when co-
cultured with strained HUVECs, the upregulated secretion of paracrine factors provided 
directional cues to direct the migration of HASMCs by 2-fold (Figure 5.7C-D) towards 
the migrating HUVEC colony. 
 
5.4 Discussion 
The results in this study demonstrate that cyclic strain can activate cues that result in 
directing HASMC migration towards HUVECs via a PDGF strain-regulated paracrine 
signaling mechanism. Cyclic strain increased HASMC responsiveness to PDGF and the 
directional migration of HASMCs towards cyclic strained HUVECs. 
 
Previous studies report directing migration through immobilizing growth factors on 
culture surface31, 32, or chemotaxis chambers that generate gradients33, 34.  A functional 
concentration gradient retains the concentration differential over time to enable 
visualization of the cell trajectories and migration velocities.  Our method is unique 
because it employs a continuously generating chemotactic source where growth factors in 
other approaches that either immobilize factors, or delivery them at time gaps35 would 
need to address the consumption and depletion of factors on culture surfaces or the lack 
of a gradient due to bolus applications.  Altering the PDMS substrate in order to establish 
local differentials in strain for the purpose of directing SM growth migration is, to the 
best of our knowledge, not been previously documented.  Others have attempted to 
 118
mimic local control cell migration to soluble stimuli by varying the extent to which the 
cells could spread over ECM36, 37.  However, our model is based on creating a substrate 
that is homogeneously treated to assess migration affects solely in response to strain.  
Lastly, although a 3-dimensional culture would provide a more physiologically relevant 
culture environment, technical inabilities to seed isolated (array of cell colonies, at time 
co-culture of HASMC and HUVECs) and precise (size of each colony precisely overlaid 
onto strain patterning locales) colonies of vascular cells limited our studies to monolayer 
culture.   
 
Cyclic tensile strain was found in this study and by others38 to enhance the expression of 
PDGF-Rβ on HASMCs.  This enhanced responsiveness of signaling via the tyrosine 
kinase pathway (activated by ligand binding to PDGF-R) may implicate the mechanism 
by which cyclic strain upregulates HASMC migration.  Cyclic strain regulation of 
molecules associated with the intracellular signaling pathway of PDGF-R has been 
widely documented, and was found to modulate ERK1/239, 40,PI3K41, p2142, 43, tyrosine 
kinase40, 44, and RhoA.  However, the likelihood that cyclic strain may be enhancing other 
receptors is high, in particular stress response factors or other signaling molecules, all 
which may cooperatively lead to complex intracellular signaling pathways.  The 
limitations of our studies in only detecting activation of one molecule may not be the 
most comprehensive in terms of understanding the overall strain mediated effects. 
 
The sequential regulation by cyclic tensile strain on early (secretion of Ang2 followed by 
PDGF by HUVECs) and late (PDGF and strain activated recruitment of SM migration 
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towards HUVECs) stages of vascular remodeling, represents a highly relevant and critical 
role for mechanical signaling in angiogenesis.  Reciprocal signaling of EC-induced SMC 
recruitment via PDGF has been examined in vivo9, 45 but not with events activated by 
external mechanical stimuli.  None of the above described reciprocal signaling 
phenomenon in response to strain, has been documented in vitro.   
 
The results of these studies demonstrate that modulating the presentation of substrate 
strain, can direct HASMC recruitment towards strain regulated HUVECs via paracrine 
intercellular signaling.  Although beyond the scope of studies performed here, the 
possibility that other paracrine factors activated by straining ECs likely exist to contribute 
to the enhancing effect on SMCs.  However, the results here identify one clear 
mechanism and provide added understanding of the role cyclic strain in the intercellular 
interaction governing SMC and HUVEC in context of neovessel formation during early 
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SUMMARY, CONCLUSIONS, IMPLICATIONS AND FUTURE DIRECTIONS 
 
6.1 Summary  
The completion of this thesis brings together device development, molecular biology, 
engineering and material studies to address whether cyclic strain can direct vascular cells 
throughout specific, concerted stages of angiogenesis.   
 
The first aim focused on developing a high precision strain device designed to 
concurrently run a large number of studies in parallel, and on creating custom elastomeric 
culture wells to present defined strain profiles for both 2D and 3D.  Vascular cell studies, 
in aims 2 and 3, utilized this strain system to critically examine the role of cyclic tensile 
strain in regulating vascular cells during early and late stage angiogenesis.   
 
Application of cyclic strain enhanced the migration and sprout formation of endothelial 
cells (Figure 4.3).  In addition, cyclic strain was found to increase secretion of angiogenic 
cytokines, primarily Angiopoietin-2 (Figure 4.4B) and PDGF (Figure 4.4A) by ECs.  
Exogenous Ang-2 was also found to mediate EC migration (Figure 4.5E) and sprout 
formation (Figure 4.5A).  However, RNAi knockdown of Ang-2 production by ECs 
 127
decreased EC responsiveness to strain regulated processes of migration (Figure 4.6C) and 
sprout formation (Figure 4.6D).   
 
Increasing levels of cyclic strain magnitudes regulated the average velocity of EC and 
SMC migration (Figure 5.3 and 5.4), and EC directionality (Figure 5.3C).  Cyclic strain 
enhanced SM expression of PDGF-receptor (Figure 5.6A).  Chemotactic effects by 
exogenous rhPDGF on SM were validated (Figure 5.5A) and secreted PDGF by ECs 
yielded similar enhancing effects SM migration (Figure 5.5D).   
 
6.2 Conclusions 
We can therefore draw several conclusions from the results summarized above.  The 
computer controlled strain device enabled the application of high precision strain and the 
ability to systematically characterize vascular cell phenotype and protein production 
necessary for our studies.  The enhanced EC angiogenic phenotypes, represented by 
migration and sprout formation, demonstrated a clear role for mechanical cues in 
angiogenesis.  Moreover, autocrine signaling via activation of Ang-2 may be the 
mechanistic pathway by which endothelial cells transduce mechanical signals to process 
a physiologic, angiogenic response.  Cyclic strain modulated the intercellular 
communication between EC and SMC by upregulating chemotactic paracrine factors 
secreted by ECs to recruit SMCs.  A co-culture model system examining vascular cell 
interactions during angiogenesis enabled us to conclude that local strain gradients 
regulate chemotactic gradients to direct ECs and SMCs, respectively.  Our studies 
showed that the application of precise local cyclic tensile strain signals enables one to 
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regulate the behavior of cells at the molecular level by regulating autocrine and paracrine 
signals between vascular cells, to ultimately direct angiogenic phenotypes at physiologic 
length scales. 
 
6.3 Implications and Future Directions 
The results from this thesis demonstrate that vascular cells, when exposed to mechanical 
stimuli, are capable to secrete factors necessary to induce physiologically relevant 
angiogenic responses.   
 
The SMART system developed in this thesis provides a platform to quantitatively assess 
the role of cyclic mechanical strain on tissue development.  Physiologically, numerous 
tissues are exposed to either a sustained, occasional, or a continuous level of strain.  The 
ability of cells in various tissues types to accommodate strains from the time of 
development throughout adult life suggest that strain signals may hold a regulatory 
homeostatic cue.  Our studies have shown that cyclic mechanical strain plays an 
important role in altering blood vessel homeostasis.  Many diseased states represent cases 
where tissues either lack or lose the ability to transduce normal levels of mechanical 
signals e.g. mechanically flawed tissues, such as atherosclerotic lesions1 or change in 
mechanical stiffness in cancerous tissues2, 3.  The strain system and the ability to present 
specific levels of strain will allow one to understand the role of strain signals and the 
complex combinatorial effect with its interaction with endogenous cues. 
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The ability to evaluate strain effects on neovascularization in 3D substrates, developed 
and utilized in this thesis, provides knowledge essential to understanding the mechanisms 
that regulate this process in a more physiologically relevant environment.  This system 
enables one to advance further and engineer 3D strain gradient fields to induce the 
formation of networks, crucial and representative of various organs throughout our 
physiology.  A possible approach to achieve 3D strain gradients can be the use of 
spatially patterned crosslinked polymers (PDMS, collagen, alginate, etc.).  Such 
variations in material properties could be achieved by applying photolithographic 
methods.  The studies performed here advance and provide a crucial tool set to better 
delineate how mechanical properties and the material interactions of cells regulate tissue 
formation. 
 
Analysis of intercellular communication between vascular cells via paracrine signaling 
using a novel co-culture system revealed that ECs and SMCs, in the context of 
angiogenesis, are highly dependent on strain-mediated mitogenic signals.  To address the 
role of strain in the development of other tissue types, proper management of the 
diffusion lengths balanced with understanding the levels of strain-mediated enhancement 
of mitogenic factors can be useful in better understanding co-culture interaction and 
communication.  The knowledge gained from these in vitro models gives insight to the 
role of strain signals derived from the pulsation of blood flow, and can be used as a 
model system to study intercellular communication in other co-culture systems. 
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Knowledge from these studies can impact clinical approaches to curing vascular diseases 
by contributing to our current understanding of critical cues that regulate vascular 
development4.  By understanding the key factors of how these processes develop can also 
aid in understanding how these similar processes fail during diseased states5.  Current 
tissue engineering approaches rely primarily on engineering delivery systems for 
mitogenic molecules.  Understanding how physiologic networks of interactions, 
mechanical stimuli and bioactive molecules, function together in the physical context of 
living cells and tissues is a challenge for future research.  In the native environment, cells 
are exposed to numerous and simultaneous signals.  Therefore, elucidating how cells 
selectively detect and filter signals to produce one concerted response could have large 
impact on a number of therapeutic approaches to diseases extending beyond those 
associated with blood vessel failure.  An environment that is oversaturated with mitogens 
would not likely be the most appropriate approach.  Thus, an alternative approach to 
using engineered delivery systems is to induce formation of vascular networks directly 
during tissue formation. An improved understanding of how mechanical signals induce 
activation of angiogenic processes has important implications.  Mechanical signals can 
influence large length scales that are physiologically relevant, which greatly exceed those 
accessible to diffusional mass transport of purely chemical stimuli.  Diffusional mass 
transport is limited to a few hundred micrometers, and is therefore fails to fully explain 
how mitogens alone can influence physiologic distances during adult vascular remodeling.  
The use of mechanical fields as signaling pathways may enable organisms to overcome 
the intrinsic length scale limitations and apply directed signals simultaneously to wide 
ranges of length scales to induce complex local angiogenic processes.  Mechanical 
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signals thereby play a role as a key signaling mechanism to complements chemotactant 
stimulation.  Since mechanical signals are present over a broad range of length scales, 
angiogenesis can be induced at multiple locations, independently.  This multitude of local 
nucleation sites leads to the characteristic fractal structures of blood vessel networks, 
where local mitogenic factors come into play to regulate anastomosis of existing vessels, 
as illustrated in Figure 6.1.  The SMART, strain gradient surfaces, 3D delivery of strain 
and a strain gradient co-culture system development and utilized throughout this thesis 




































Figure 6.1: Suggestion for a new tissue Engineering Approach 
The concept is based on creating vascular networks using cyclic tensile strain to 
overcome the diffusional mass transport limitation (approximately 200 um). This method 
addresses the question how mitogens alone can influence physiologic distances of 
vascular formation in tissue engineered constructs. Mechanical fields are used as 
signaling pathways to overcome the intrinsic length scale limitations, by applying 
directed signals across the entire tissue construct to induce multiple sites of local 
angiogenic activation.  The multitude of local nucleation sites then leads to the 
characteristic fractal structures of blood vessel networks.  Subsequent anastomosis of 
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Protocol to create Mosaic Images 
This script will systematically capture and combine over 100 images (using a 10x 
objective) to create a high resolution mosaic image of your sample on a macro-scale (ex: 
sample 10x10mm).  It is programmed in IPLAB 4.0 and fully automated for use on 
Olympus IX81 (Mooney Lab, ESL-4th floor inverted fluorescence) and requires a 
functional computer controlled stage.  
Useful for: imaging whole histological samples or migration of localized cell colony. 
 
Scripts required 
Main script (choose one depending on need) 
For DIC images:    YC array mosaic non6D.IPS 
For DAPI + GFP images:  YC array mosaic non6D FL.IPS 
Supplemental script (required) 
Array yu ching grab dapi_fitc.IPS 
 
Method 
1. Open script (choose one depending on need): 
2. Bring focus to upper left corner to sampling image locale. 
3. Focus and (if applicable) select exposure time  
4. Press continue 
5. Calculate # images in x-dir and y-dir you require:  (see conversion table below) 
    Conversion Table for image pixel (at 10x) : length (um) 
(at 10x) 1307.11 pixels = 780um  
Unit conversion = 0.596 um/pixel  
Full frame (at 10x) =  (1392 x 1040) pixels/frame = (830 x 620) um2/frame  
Example: if you want a mosaic image that has a sample length in the x-dir = 3 mm,  
you should enter  (image # in x-dir =  4   , overshooting slightly). 
6. Press run (time to complete, ranges from 2-5 minutes) 
 
Script and samples mosaic image 






































Protocol to Pattern Array of Vascular Cell Colonies 
 
 
 
